<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">100396</article-id><article-id pub-id-type="doi">10.7554/eLife.100396</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>A single-cell atlas of the testicular interstitium defines Leydig progenitor networks sustaining Leydig cell homeostasis across the lifespan</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Huang</surname><given-names>Xiaojia</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0005-1477-1644</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Xia</surname><given-names>Kai</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Yang</surname><given-names>Meiling</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Hong</surname><given-names>Mengzhi</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Jiang</surname><given-names>Meihua</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Weiqiang</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Lei</surname><given-names>Zhenmin</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Xiang</surname><given-names>Andy Peng</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3409-5012</contrib-id><email>xiangp@mail.sysu.edu.cn</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Zhao</surname><given-names>Wei</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0774-2571</contrib-id><email>zhaowei23@mail.sysu.edu.cn</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0064kty71</institution-id><institution>Department of Sports Medicine, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University</institution></institution-wrap><addr-line><named-content content-type="city">Guangzhou</named-content></addr-line><country>China</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0064kty71</institution-id><institution>Center for Stem Cell Biology and Tissue Engineering, Key Laboratory for Stem Cells and Tissue Engineering, Ministry of Education, Sun Yat-sen University</institution></institution-wrap><addr-line><named-content content-type="city">Guangzhou</named-content></addr-line><country>China</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01vjw4z39</institution-id><institution>Medical Research Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University</institution></institution-wrap><addr-line><named-content content-type="city">Guangzhou</named-content></addr-line><country>China</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03wnxd135</institution-id><institution>Central Laboratory, The Second Affiliated Hospital of Fujian Medical University</institution></institution-wrap><addr-line><named-content content-type="city">Quanzhou</named-content></addr-line><country>China</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/037p24858</institution-id><institution>Department of Laboratory Medicine, The First Affiliated Hospital of Sun Yat-sen University</institution></institution-wrap><addr-line><named-content content-type="city">Guangzhou</named-content></addr-line><country>China</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01ckdn478</institution-id><institution>Department of OB/GYN and Women’s Health, University of Louisville School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Louisville</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Postovit</surname><given-names>Lynne-Marie</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02y72wh86</institution-id><institution>Queen's University</institution></institution-wrap><addr-line><named-content content-type="city">Kingston</named-content></addr-line><country>Canada</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Postovit</surname><given-names>Lynne-Marie</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02y72wh86</institution-id><institution>Queen's University</institution></institution-wrap><addr-line><named-content content-type="city">Kingston</named-content></addr-line><country>Canada</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>23</day><month>12</month><year>2025</year></pub-date><volume>14</volume><elocation-id>e100396</elocation-id><history><date date-type="received" iso-8601-date="2024-06-06"><day>06</day><month>06</month><year>2024</year></date><date date-type="accepted" iso-8601-date="2025-12-23"><day>23</day><month>12</month><year>2025</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2024-08-06"><day>06</day><month>08</month><year>2024</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.08.02.606288"/></event></pub-history><permissions><copyright-statement>© 2025, Huang, Xia, Yang et al</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Huang, Xia, Yang et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-100396-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-100396-figures-v2.pdf"/><abstract><p>Declining rates of male fertility pose a significant clinical challenge, while the mechanisms underlying testicular interstitial function remain incompletely understood. Here, we conducted a comprehensive analysis of the single-cell transcriptomic landscape of the murine testicular interstitium across the postnatal lifespan. The investigation unveiled a previously unrecognized population of Cd34<sup>+</sup>/Sox4<sup>+</sup> mesenchymal cells nestled within the interstitium, hinting at their potential as Leydig cell (LC) progenitors. With the aging process of Cd34<sup>+</sup>/Sox4<sup>+</sup> mesenchymal cells, we observed a decline in glutathione levels within the testicular interstitium. Remarkably, these Cd34<sup>+</sup>/Sox4<sup>+</sup> mesenchymal cells exhibited clonogenic self-renewal capacity and a robust propensity to differentiate into LCs. Intriguingly, when transplanted into LC-disrupted or failure models, Cd34<sup>+</sup>/Sox4<sup>+</sup> cells efficiently colonized the testicular interstitium, resulting in a notable increase in testosterone production. Exploring the epigenetic landscape, we identified critical transcription factors, most notably Sox4, governing the stem cell fate of Cd34<sup>+</sup>/Sox4<sup>+</sup> mesenchymal cells. Overall, this comprehensive lifespan-resolved single-cell atlas of testicular interstitial cells provides fundamental insights into LC progenitor biology and regenerative capacity during aging.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>single-cell transcriptomics</kwd><kwd>testicular interstitium</kwd><kwd>mesenchymal cells</kwd><kwd>Leydig cell</kwd><kwd>glutathione metabolism</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution>National Key Research and Development Program of China</institution></institution-wrap></funding-source><award-id>2023YFC2506100</award-id><principal-award-recipient><name><surname>Zhao</surname><given-names>Wei</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01h0zpd94</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>82303201</award-id><principal-award-recipient><name><surname>Yang</surname><given-names>Meiling</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution>National Key Research and Development Program of China</institution></institution-wrap></funding-source><award-id>2017YFA0103800</award-id><principal-award-recipient><name><surname>Zhao</surname><given-names>Wei</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/045kpgw45</institution-id><institution>High-level Hospital Construction Project of Guangdong Provincial People's Hospital</institution></institution-wrap></funding-source><award-id>DFJHBF202102</award-id><principal-award-recipient><name><surname>Zhao</surname><given-names>Wei</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Single-cell transcriptomic analysis of the murine testicular interstitium across the lifespan reveals Cd34<sup>+</sup>/Sox4<sup>+</sup> mesenchymal cells as Leydig progenitors, whose aging-associated decline in glutathione and Sox4-regulated regenerative capacity inform potential therapeutic strategies for age-related testicular dysfunction.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Declining male fertility has become a significant social and medical concern, with male factors contributing to roughly half of infertility cases. A considerable proportion of male infertility is linked to dysfunctions in the testicular interstitium. Among interstitial cells, Leydig cells (LCs) are crucial for male reproductive function, as they produce testosterone essential for male sexual development and fertility (<xref ref-type="bibr" rid="bib7">Ge et al., 2008</xref>; <xref ref-type="bibr" rid="bib8">Haider, 2004</xref>; <xref ref-type="bibr" rid="bib20">Potter and DeFalco, 2017</xref>; <xref ref-type="bibr" rid="bib35">Zirkin and Papadopoulos, 2018</xref>). During fetal development, LCs drive the masculinization of the reproductive tract and external genitalia, and in adulthood, they maintain male secondary sexual characteristics and support spermatogenesis (<xref ref-type="bibr" rid="bib6">Forest, 1983</xref>). Despite their importance, our understanding of LC development, especially the maintenance of the adult LC population during aging, remains incomplete.</p><p>It is well established that two waves of LCs arise in the testis: fetal Leydig cells (FLCs) and adult Leydig cells (ALCs) (<xref ref-type="bibr" rid="bib5">DeFalco et al., 2011</xref>). FLCs emerge during fetal testis development and largely regress after birth, with only a small subset persisting into adulthood (<xref ref-type="bibr" rid="bib17">Liu et al., 2016</xref>; <xref ref-type="bibr" rid="bib24">Shima et al., 2015</xref>; <xref ref-type="bibr" rid="bib25">Shima et al., 2018</xref>; <xref ref-type="bibr" rid="bib29">Wen et al., 2016</xref>). ALCs differentiate at puberty and are responsible for sustaining testosterone production throughout adult life. However, ALCs are generally considered terminally differentiated and have a limited capacity for proliferation or regeneration (<xref ref-type="bibr" rid="bib2">Chamindrani Mendis-Handagama and Siril Ariyaratne, 2001</xref>; <xref ref-type="bibr" rid="bib18">Midzak et al., 2009</xref>). This makes the adult LC population susceptible to age-related decline and dysfunction. Elucidating how the LC pool is maintained or replenished under physiological and aging conditions is therefore of great interest for understanding and potentially treating age-related hypogonadism.</p><p>Previous studies have suggested the existence of stem or progenitor cells that give rise to new LCs during postnatal life. For instance, Nestin-expressing cells in the peritubular region were identified as putative stem LCs in the adult testis (<xref ref-type="bibr" rid="bib12">Jiang et al., 2014</xref>; <xref ref-type="bibr" rid="bib33">Zang et al., 2017</xref>). Similarly, other markers have been associated with progenitor-like interstitial cells, such as CD51 (integrin α_v) and Tcf21, indicating that a reserve population capable of LC differentiation might reside in the testicular interstitium (<xref ref-type="bibr" rid="bib23">Shen et al., 2021</xref>; <xref ref-type="bibr" rid="bib33">Zang et al., 2017</xref>). Nonetheless, the exact identity and characteristics of an adult LC progenitor population have remained elusive. Recent advances in single-cell RNA sequencing (scRNA-seq) provide an opportunity to resolve cellular heterogeneity and identify rare cell types in the testis, which could shed light on such progenitor cells and their behavior across different ages.</p><p>In this study, we performed comprehensive single-cell transcriptomic profiling of the mouse testicular interstitium at key postnatal stages (neonatal, adolescent, adult, middle-aged, and aged) to investigate how Leydig progenitor populations sustain LC homeostasis across the lifespan. Our analysis uncovered a previously unrecognized population of Cd34<sup>+</sup>/Sox4<sup>+</sup> mesenchymal progenitors, which represent a key component of this regenerative network. These Cd34<sup>+</sup>/Sox4<sup>+</sup> mesenchymal cells are enriched in early postnatal testes and decline in abundance with age, suggesting a developmental regulation of this cell population. The observations demonstrate that they possess clonogenic self-renewal capacity and can differentiate into functional LCs in vitro. In vivo, transplantation of Cd34<sup>+</sup>/Sox4<sup>+</sup> cells into LC-depleted adult testes resulted in efficient engraftment and an increase in testosterone-producing LCs, underscoring their regenerative potential. Subsequent epigenomic analyses identify Sox4 as a critical transcription factor maintaining the stem-like state of these cells. Together, these findings define Cd34<sup>+</sup>/Sox4<sup>+</sup> mesenchymal progenitors as an integral component of the broader Leydig progenitor network that collectively maintains LC regeneration and homeostasis throughout life. This insight provides a mechanistic framework for understanding age-related LC decline and lays the groundwork for developing cell-based therapies for testosterone deficiency and male infertility.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Single-cell transcriptomic analysis reveals LC heterogeneity in testicular interstitium</title><p>To comprehensively characterize interstitial cell populations within mouse testes, we employed flow cytometry to enrich interstitial cell fractions, maximizing their representation (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). Samples were collected at pivotal developmental stages: neonatal (1 week), adolescent (1 month), adult (2 months), middle-aged (8 months), and aged (24 months). scRNA-seq was performed on these samples utilizing the 10x Genomics Chromium platform (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Through uniform manifold approximation and projection (UMAP) analysis, we identified five major cell types, each defined by hallmark gene expression profiles from existing literature: spermatogenic cells (<italic>Prm1</italic>, <italic>Oaz3</italic>, <italic>Dbil5</italic>), Sertoli cells (<italic>Wt1</italic>, <italic>Sox9</italic>, <italic>Amh</italic>), immune cells (<italic>Cd45</italic>, <italic>Cd68</italic>, <italic>Cd74</italic>), mesenchymal cells (<italic>Dcn</italic>, <italic>Col1a2</italic>, <italic>Col3a1</italic>), and LCs (<italic>Nr5a1</italic>, <italic>Cyp17a1</italic>, <italic>Hsd3b1</italic>) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B, C</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Characterization of cell populations in the mouse testicular interstitium.</title><p>(<bold>A</bold>) Schematic overview of the experimental design for single-cell RNA sequencing conducted on mouse testicular interstitium samples across multiple developmental stages (neonatal, adolescent, adult, middle-aged, and aged), with three replicates at each stage. (<bold>B</bold>) Uniform manifold approximation and projection (UMAP) visualization illustrating the heterogeneity and distribution of distinct cell types within the testicular interstitium across developmental stages. (<bold>C</bold>) UMAP visualization displays various developmental phases: neonatal (1 week), adolescent (1 month), adult (2 months), middle-aged (8 months), and aged (24 months). (<bold>D</bold>) Heatmap displaying the top 10 differentially expressed genes (DEGs) for each identified cell cluster. (<bold>E</bold>) Dot plot summarizing enriched Gene Ontology (GO) terms corresponding to each cell cluster, highlighting their distinct biological functions. (<bold>F</bold>) Violin plots demonstrating expression patterns of representative marker genes used to identify key interstitial cell populations. (<bold>G</bold>) Quantification of cell type proportions within the testicular interstitium across the different developmental stages. (<bold>H</bold>) Immunofluorescence staining revealing a subpopulation of ambiguous cells (ACs) characterized by co-expression of LC marker, Hsd3b1, and macrophage marker, F4-80, indicated by yellow fluorescence. Scale bar: 50 µm. (<bold>I</bold>) Immunofluorescence labeling for Hsd3b1 and Cd34 to distinguish LCs from MCs within the 2-week-old testicular interstitium. Scale bar: 50 µm. (<bold>J</bold>) Quantitative analysis of Cd34<sup>+</sup> MCs within the testicular interstitium across different developmental stages.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100396-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Single-cell transcriptome profiling of the mouse testicular interstitium.</title><p>(<bold>A</bold>) Isolation of mouse testicular interstitial cells via fluorescence-activated cell sorting (FACS) for single-cell RNA sequencing (scRNA-seq). (<bold>B</bold>) A uniform manifold approximation and projection (UMAP) visualization showing all identified cell types from scRNA-seq, with analysis focused exclusively on cells from the testicular interstitium. (<bold>C</bold>) Dot plot displaying characteristic differentially expressed genes (DEGs) across identified cell types. (<bold>D</bold>) UMAP representation highlighting distinct cell populations within the mouse testicular interstitium across neonatal, prepubertal, adolescent, adult, and aged stages in mice. (<bold>E</bold>) UMAP plot showing expression patterns of selected marker genes. (<bold>F</bold>) Heatmap presenting the differentially DEGs between AC and LC. (<bold>G</bold>) Gene Ontology (GO) enrichment analysis of AC-upregulated and AC-downregulated DEGs (compared with LC). Gene expression levels are scaled and colored based on Z-scores, while enrichment significance is indicated by color and adjusted p-values. (<bold>H</bold>) Heatmap presenting the DEGs between AC and macrophages. (<bold>I</bold>) GO enrichment analysis of AC-upregulated and AC-downregulated DEGs (compared with macrophages). Gene expression levels are scaled and colored based on Z-scores, while enrichment significance is indicated by color and adjusted p-values.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100396-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Dynamic functional changes of testicular macrophages across the postnatal lifespan.</title><p>(<bold>A</bold>) Pseudotime trajectory analysis for macrophages across five postnatal developmental stages, depicted with distinct colors. (<bold>B</bold>) Heatmap illustrating temporal shifts in GO term enrichment for macrophages, mapped along the pseudotime continuum. (<bold>C</bold>) Expression trend plots for selected genes within macrophages across pseudotime, associated with processes such as proliferation, antigen processing and presentation, proteasomal protein degradation, and glutathione metabolism. (<bold>D</bold>) Violin plots reveal changes in functional scores for macrophages during development, assessing aspects such as migration, antigen processing and presentation, phagocytosis, cytokine production, and M1/M2 polarization. (<bold>E</bold>) Circle diagrams depict key signaling pathways initiated by macrophages, highlighting VCAM, IGF, VISFATIN, and GAS pathways. Edge colors match the signaling sources, and the width of each edge denotes the likelihood of communication, with thicker lines indicating more robust signaling.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100396-fig1-figsupp2-v2.tif"/></fig></fig-group><p>Detailed analysis revealed ten distinct interstitial subpopulations, encompassing well-defined cell types such as LCs, mesenchymal cells (MCs), endothelial cells (ECs), and multiple immune subsets including macrophages (MPs), monocytes (MNCs), natural killer T cells (NKTCs), and B lymphocytes (BCs) (<xref ref-type="fig" rid="fig1">Figure 1B, C</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D, E</xref>). Additionally, unsupervised clustering characterized two proliferative subpopulations: Mki67-LCs, exhibiting high expression of mitotic markers (<italic>Mki67</italic>, <italic>Cenpa</italic>) alongside classical LC markers (<italic>Hsd3b1</italic>, <italic>Star</italic>), and Mki67-MCs, defined by DNA replication-associated genes (<italic>Hells</italic>, <italic>Lig1</italic>) and mesenchymal markers (<italic>Dcn</italic>, <italic>Col1a2</italic>) (<xref ref-type="fig" rid="fig1">Figure 1B–D</xref>).</p><p>Notably, unsupervised clustering also identified an unexpected cell population exhibiting a mixed gene expression signature of both macrophages and LCs, designated as ambiguous cells (ACs) (<xref ref-type="fig" rid="fig1">Figure 1D, F</xref>). Gene Ontology (GO) analysis of AC-specific differentially expressed genes (DEGs) highlighted involvement in tumor necrosis factor production, hormone metabolism, and response to reactive oxygen species (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). The AC population showed rapid expansion during adolescence, followed by a significant decline and stabilization at lower proportions in adulthood and aging (<xref ref-type="fig" rid="fig1">Figure 1G</xref>). Comparative transcriptomic analysis revealed AC-specific upregulation of DEGs associated with responses to external stimuli relative to LCs (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1F, G</xref>), as well as enrichment of hormone metabolism pathways compared to macrophages (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1H, I</xref>).</p><p>The single-cell profiling observed significant age-related increases in immune cell populations, notably macrophages, B lymphocytes, and T lymphocytes (<xref ref-type="fig" rid="fig1">Figure 1G</xref>). Additionally, the analysis uncovered a previously undescribed mesenchymal subpopulation, Cd34-MCs, prominently present during neonatal stages and progressively declining with maturation (<xref ref-type="fig" rid="fig1">Figure 1G</xref>). Further immunofluorescence staining validated the presence and localization of ACs within the testicular interstitium (<xref ref-type="fig" rid="fig1">Figure 1H</xref>) and confirmed the sharp reduction of Cd34-MCs post-puberty (<xref ref-type="fig" rid="fig1">Figure 1I, J</xref>).</p><p>To further elucidate immune cell dynamics, we investigated temporal transcriptional changes across immune populations from neonatal to aged stages (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref>). Macrophages, notably abundant within the adult interstitium, exhibited significant transcriptional shifts throughout development (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2B–D</xref>). CellChat analyses identified consistent macrophage interactions with LCs and Cd34-MCs via the Vcam signaling pathway at all examined stages, suggesting Vcam’s role in facilitating macrophage adhesion or migration into testicular tissue. Notably, Vcam pathway signaling intensity markedly decreased by 24 months. Additionally, macrophages were found to secrete factors including Igf1 and Visfatin (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2E</xref>), potentially enhancing steroidogenic activity within LCs (<xref ref-type="bibr" rid="bib9">Hameed et al., 2012</xref>; <xref ref-type="bibr" rid="bib11">Jeremy et al., 2017</xref>; <xref ref-type="bibr" rid="bib16">Lin et al., 1986</xref>; <xref ref-type="bibr" rid="bib19">Ocón-Grove et al., 2010</xref>).</p></sec><sec id="s2-2"><title>Dynamic gene expression patterns in interstitial cells from infancy to adulthood</title><p>Clustering analysis revealed continuous groupings among LCs, ACs, and MCs, prompting a focused re-clustering of LCs and MCs across developmental stages. This refined clustering yielded seven distinct subpopulations, consistent with previously established research and marker genes: Cd34-MCs, Mki67-positive MCs (Mki67-MC), progenitor LCs (PLC; <italic>Hsd3b6</italic>, <italic>Cyp51</italic>), immature LCs (ILC; <italic>Cyp17a1</italic>), mature LCs (MLC; <italic>Hsd3b1</italic>), Mki67-positive LCs (Mki67-LC), and AC (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). Additional novel markers specific to each cell type were identified, including <italic>Lcn2</italic> and <italic>Ptgds</italic> for ILCs, <italic>Cyp51</italic> and <italic>Ass1</italic> for PLCs, and <italic>Kcnk3</italic> and <italic>Agt</italic> for MLCs (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). The heatmap illustrates the top 10 DEGs and representative markers for each cell cluster (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). GO analysis of these DEGs provided functional insights, highlighting their involvement in diverse cellular processes (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>). Examination of LC and MC differentiation trajectories, informed by testosterone biosynthesis gene expression patterns, supported a progressive differentiation pathway, suggesting that LCs likely originate from MCs yet exhibit distinct functional properties (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D, E</xref>). Furthermore, we validated key transcriptomic distinctions at the protein level, confirming differential expression patterns among Mki67-LCs, ACs, PLCs, and MLCs (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1F, G</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Identification and characterization of dynamic Cd34-MC and LC subpopulations across developmental stages.</title><p>(<bold>A</bold>) Uniform manifold approximation and projection (UMAP) visualization illustrating distinct cell populations within mouse testicular interstitium at various developmental stages (neonatal, adolescent, adult, middle-aged, and aged). (<bold>B</bold>) Dot plot depicting key differentially expressed genes (DEGs) characterizing each Leydig cell subtype. (<bold>C</bold>) Monocle-generated pseudotime trajectory tracing developmental transitions and differentiation paths among Leydig cell subtypes. (<bold>D</bold>) Pseudotime analysis revealing dynamic developmental transitions specifically enriched in progenitor Cd34-MC1 cells toward mature Leydig cell lineages. (<bold>E</bold>) Heatmap of top DEGs and their corresponding Gene Ontology (GO) terms enriched within the Cd34-MC subsets. (<bold>F</bold>) Pseudotime plot highlighting gene expression patterns unique to Cd34-MC1 cells. (<bold>G</bold>) Representative immunofluorescence images demonstrating co-localization of Cd34 and Sox4 in interstitial cells at 3 weeks of age. Scale bar: 10 µm. (<bold>H</bold>) UMAP visualization showing the distribution of human interstitial cell populations across infant and adult testicular samples (data sourced from GSE124263). (<bold>I</bold>) Pseudotime trajectory analysis elucidating developmental trajectories of human testicular interstitial cell populations. (<bold>J</bold>) UMAP plots highlighting the distribution of CD34-MC subpopulations in human testes across developmental stages. (<bold>K</bold>) Violin plots illustrating relative gene expression (<italic>z</italic>-score normalized log-transformed values) of indicated genes in Cd34-MC subpopulations.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100396-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Subpopulation classification within Leydig cell (LC) and mesenchymal cell (MC) across developmental stages.</title><p>(<bold>A</bold>) UMAP visualization showing LC and MC subtypes across various developmental phases: neonatal (1 week), adolescent (1 month), adult (2 months), middle-aged (8 months), and aged (24 months). (<bold>B</bold>) Heatmap of the top ten differentially expressed genes for each LC and MC subtype, with expression levels normalized and visualized through a Z-score-based color gradient. (<bold>C</bold>) GO enrichment analysis for each LC subtype, with significance indicated by color corresponding to adjusted p-values. (<bold>D</bold>) Schematic representation of testosterone biosynthesis, emphasizing genes implicated in the process. (<bold>E</bold>) Dot plot detailing gene expression relevant to testosterone synthesis across stages of LC lineage differentiation. (<bold>F</bold>) Immunofluorescence staining of testis sections showing the expression patterns of representative markers distinguishing Mki67⁺ Leydig cells (Mki67-LC), ambiguous cells (ACs), progenitor Leydig cells (PLCs), and mature Leydig cells (MLCs). (<bold>G</bold>) Immunofluorescence staining of in vitro–cultured cells demonstrating the expression of representative markers: Col1a1, Plin1, Cyp51, and Hsd3b1. (<bold>H</bold>) Pseudotime trajectory analysis delineates differentiation pathways from undifferentiated MCs towards mature LCs, showcasing expression evolution within the LC lineage from neonatal to aged stages.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100396-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Molecular characterization of Cd34<sup>+</sup> mesenchymal cell (MC) subpopulations.</title><p>(<bold>A</bold>) Dot plot illustrating expression profiles of previously reported stem Leydig cell (SLC) markers across distinct Leydig cell subtypes. (<bold>B</bold>) Dot plot illustrating expression profiles of previously reported SLC markers in Cd34⁺ MC subpopulations across defined age cohorts. (<bold>C</bold>) Violin plots depicting the expression patterns of previously reported SLC markers across distinct Cd34⁺ MC subpopulations. (<bold>D</bold>) Violin plots showing the expression patterns of novel SLC markers across distinct Cd34⁺ MC subpopulations. (<bold>E</bold>) UMAP analysis reveals cell type distribution within the testicular interstitium of infant (n=2) and adult (n=2) human testes, based on the public dataset GSE124263. (<bold>F</bold>) Dot plot illustrates marker gene expression profiles, identifying key cell types within the human testicular interstitium. (<bold>G</bold>) Pseudotime trajectory analysis delineates differentiation pathways from infancy (dark blue) to adulthood (light blue) stages. (<bold>H</bold>) Pseudotime analysis reveals dynamic gene expression profiles and developmental transitions towards LC lineages within the testicular interstitium of human testes.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100396-fig2-figsupp2-v2.tif"/></fig></fig-group><p>To further elucidate the developmental relationships and differentiation trajectories among LC populations, we conducted pseudotime trajectory analysis across different developmental stages. Significant variations in gene expression profiles were observed between early postnatal (1-week-old) and adult stages. The Cd34-MC population diverged into three distinct subtypes (Cd34-MC1, Cd34-MC2, and Cd34-MC3) with increasing age (<xref ref-type="fig" rid="fig2">Figure 2C, D</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1H</xref>). Comparative analysis of their transcriptional profiles highlighted enrichment of pathways related to stem cell functions, including male gonadal development, mesenchymal development, and regenerative processes, particularly within the Cd34-MC1 subtype (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). Notably, specific markers such as <italic>Sox4</italic> exhibited prominent expression in adolescent Cd34-MC1 cells (Cd34<sup>+</sup>/Sox4<sup>+</sup>), indicating their enhanced differentiation potential compared to other subtypes (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). Immunofluorescence staining at 3 weeks of age confirmed the presence of Cd34<sup>+</sup>/Sox4<sup>+</sup> cells (<xref ref-type="fig" rid="fig2">Figure 2G</xref>), consistent with Cd34-MC1 identity at this peri-pubertal transitional stage.</p><p>To clarify whether Cd34<sup>+</sup>/Sox4<sup>+</sup> cells are SLCs, we analyzed the expression patterns of classical SLC markers across different LC subtypes. The results demonstrated that SLC markers including <italic>Arx1</italic>, <italic>Nr2f2</italic>, <italic>Pdgfra</italic>, and <italic>Tcf21</italic> were all highly expressed in Cd34<sup>+</sup>/Sox4<sup>+</sup> cells (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A</xref>). Notably, these SLC markers were almost exclusively detected in Cd34-MC1 within the testes of 1-week-old juvenile mice (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B</xref>). Furthermore, based on the classification of the Cd34-MC subpopulation, the newly identified stem/progenitor cell markers such as <italic>Sox4</italic>, <italic>Mest</italic>, <italic>Wnt5a</italic>, <italic>Ptn</italic>, and <italic>Mdk</italic> exhibit greater specificity compared to SLC markers like <italic>Arx1</italic>, <italic>Nr2f2</italic>, <italic>Pdgfra</italic>, and <italic>Tcf21</italic> (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2C, D</xref>).</p><p>Additionally, analysis of publicly available scRNA-seq data from human testes (GSE124263) identified a corresponding CD34-MC subtype in both infant and adult human testicular tissues (<xref ref-type="fig" rid="fig2">Figure 2H</xref>; <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2E, F</xref>). Pseudotime trajectory analysis suggested a conserved progenitor role for human CD34-MCs in LC lineage differentiation (<xref ref-type="fig" rid="fig2">Figure 2I</xref>; <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2G, H</xref>). Remarkably, these CD34-MC subpopulations persisted within the human testicular interstitium from infancy into adulthood, maintaining distinct transcriptional identities throughout development (<xref ref-type="fig" rid="fig2">Figure 2J, K</xref>).</p></sec><sec id="s2-3"><title>Significant reduction in glutathione metabolism within interstitial cells during aging</title><p>To characterize age-dependent transcriptional alterations in testicular interstitial cells, we conducted hierarchical clustering of cells (rows) based on the top 2000 most variably expressed genes (columns) across various age groups. This analysis delineated two primary clusters of genes with distinct age-dependent expression profiles. Genes exhibiting elevated expression in older samples included established aging markers such as <italic>Spp1</italic> and <italic>Cxcl10</italic> (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Conversely, genes showing decreased expression with aging, such as <italic>Wnt5a</italic> and <italic>Kitl</italic>, formed a distinct cluster potentially linked to protective roles against aging processes (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Gene set enrichment analysis (GSEA) demonstrated that genes with reduced expression in older samples were significantly associated with metabolic pathways, particularly cholesterol biosynthesis and steroid hormone metabolism, indicating a potential decline in steroidogenesis during aging (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). In contrast, genes upregulated with age were prominently involved in immune system pathways, highlighting enhanced activation of both innate and adaptive immune responses within the aging testicular interstitium (<xref ref-type="fig" rid="fig3">Figure 3C</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Age-associated alterations in glutathione metabolism within testicular interstitial cells.</title><p>(<bold>A</bold>) <italic>K</italic>-means clustering analysis of genes exhibiting differential expression patterns in testicular interstitial cell populations during aging. (<bold>B</bold>) Gene set enrichment analysis (GSEA) illustrating significantly downregulated metabolic pathways in aged interstitial cells (p &lt; 0.05). (<bold>C</bold>) GSEA showing enrichment of immune-related pathways among genes upregulated in older interstitial cells. (<bold>D</bold>) Targeted steroid hormone metabolomics analysis comparing the testicular lipid profile between young (3-month-old) and aged (24-month-old) mice (<italic>n</italic> = 5). (<bold>E</bold>) Dot plot illustrating correlation between upregulated metabolites and differentially expressed genes (DEGs) in aged interstitial cells. (<bold>F</bold>) Expression trends of essential glutathione metabolism pathway genes across developmental stages, highlighting decreased activity in older interstitial cells. (<bold>G</bold>) Relative abundance of reduced glutathione (GSH) quantified in testes from young (3-month-old) and aged (24-month-old) mice (<italic>n</italic> = 5, p &lt; 0.01), presented as mean ± SEM. (<bold>H</bold>) A ranked plot of super-enhancers (SEs) showcases those with the highest median H3K27ac scores across Cd34-MC1, Cd34-MC2, and Cd34-MC3 cells. (<bold>I</bold>) Representative ChIP-seq tracks displaying H3K27ac enrichment at the Nrf2 genomic locus in interstitial cells at various ages. (<bold>J</bold>) Violin plots illustrating age-associated changes in Nrf2 gene expression within the Cd34-MC1 cell population. (<bold>K</bold>) GSEA showing enrichment of reactive oxygen species (ROS)-related signaling pathways influenced by Nrf2 activity specifically in aging Cd34-MC1 cells.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100396-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Transcriptional changes and metabolic alterations in the testicular interstitium during aging.</title><p>(<bold>A</bold>) Principal component analysis (PCA) score plot demonstrating distinct metabolite profiles between the young and aged groups (n=5). (<bold>B</bold>) Volcano plot displaying differentially abundant metabolites comparing testes from 3-month-old and 24-month-old mice (n=5). (<bold>C</bold>) Heatmap showing key metabolites that differ significantly between young and aged groups. (<bold>D</bold>) Violin plot illustrates <italic>Gpx4</italic> and <italic>Gsta4</italic> expression across specific subpopulations. (<bold>E</bold>) Heatmap shows that aging-related genes in the GenAge database are expressed in testicular subpopulations of aged mice. (<bold>F</bold>) The intensity of H3K27ac at the transcription start site (TSS) in Cd34-MC1, Cd34-MC2, and Cd34-MC3 cells. (<bold>G</bold>) Protein-protein interaction (PPI) analysis indicates the involvement of Nrf2 in both glutathione and reactive oxygen species (ROS) metabolism pathways.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100396-fig3-figsupp1-v2.tif"/></fig></fig-group><p>To further investigate metabolic shifts associated with aging, untargeted metabolomics using liquid chromatography–mass spectrometry was performed on testicular tissues from young (3 months) and aged (24 months) mice. Principal component analysis indicated overall metabolic similarities among samples (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). However, volcano plot analysis identified significant metabolic alterations in aging testes, notably elevated levels of peroxidation and hydroxylation products, such as beta-hydroxymyristic acid, D-alpha-hydroxyglutaric acid, and 6-hydroxycaproic acid (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B, C</xref>). Steroid metabolome profiling further revealed a pronounced decrease in steroid hormones, particularly testosterone, in aged tissues (<xref ref-type="fig" rid="fig3">Figure 3D</xref>).</p><p>Integrating transcriptomic and metabolomic data via MetaboAnalyst 5.0 joint-pathway analysis pinpointed glutathione metabolism as a significantly affected pathway during aging (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). Consistent with this finding, an age-dependent increase in the expression of glutathione oxidase-related genes has been observed through pseudotime analysis (<xref ref-type="fig" rid="fig3">Figure 3F</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D</xref>), accompanied by a significant decline in reduced glutathione levels (<xref ref-type="fig" rid="fig3">Figure 3G</xref>). Additionally, interstitial cells from older testes demonstrated elevated expression of genes listed in the GenAge database, including <italic>Gpx4</italic> and <italic>Gsta4</italic>, indicative of heightened oxidative stress responses (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D and E</xref>).</p><p>To identify key transcription factors controlling genes involved in glutathione metabolism, super-enhancer analysis through H3K27 acetylation (H3K27ac) Cut&amp;Tag sequencing has been conducted in Cd34-MCs (<xref ref-type="fig" rid="fig3">Figure 3H</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1F</xref>). Notably, super-enhancers associated with Nrf2 were identified within Cd34-MC1 and Cd-MC2 populations but were absent in Cd34-MC3 (<xref ref-type="fig" rid="fig3">Figure 3I</xref>). Protein–protein interaction network analysis underscored a potential regulatory role of Nrf2 in orchestrating glutathione metabolism-related gene expression (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1G</xref>). Expression analysis revealed consistently high <italic>Nrf2</italic> levels from postnatal to adult stages, followed by a gradual decline in later life (<xref ref-type="fig" rid="fig3">Figure 3J</xref>). Furthermore, GSEA suggested that reduced <italic>Nrf2</italic> expression in aged LCs could contribute significantly to increased oxidative stress susceptibility (<xref ref-type="fig" rid="fig3">Figure 3K</xref>).</p></sec><sec id="s2-4"><title>Unveiling Cd34-MC1 cells as LC progenitors through transplantation into LC-disrupted and <italic>Lhcgr</italic><sup>−/−</sup> mouse models</title><p>We next evaluated the self-renewal capacity and differentiation potential of Cd34-MC cells derived from mice at two distinct developmental stages: young (2 weeks old, Cd34-MC1) and aged (24 months old, Cd34-MC3). Cd34-MC1 cells demonstrated significantly enhanced self-renewal abilities and greater clonogenic potential compared to Cd34-MC3 cells isolated from aged mice (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). Furthermore, Cd34-MC1 cells successfully differentiated into LC lineage when cultured in specialized differentiation media, whereas aged Cd34-MC2 cells exhibited limited proliferation and differentiation capacities (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>).</p><p>To evaluate the in vivo regenerative potential of Cd34-MC1 cells, we transplanted these cells into mice subjected to LC disruption using ethylene dimethanesulfonate (EDS, 200 mg/kg). Cd34-MC1 cells isolated via fluorescence-activated cell sorting (FACS) from 2-week-old mice were transplanted directly into the testicular parenchyma 4 days after EDS-induced LC disruption (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>). Serum and testicular tissues were collected at defined intervals (0, 4, 8, 12, 16, and 20 days post-EDS treatment) for subsequent analyses (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Remarkably, transplanted Cd34-MC1 cells efficiently localized within the testicular interstitium and contributed substantially to the structural regeneration of LC-depleted testes (<xref ref-type="fig" rid="fig4">Figure 4B</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D</xref>). Notably, transplantation led to a significant increase in Hsd3b1-positive LCs within recipient testes compared to controls (<xref ref-type="fig" rid="fig4">Figure 4C</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Cd34-MC1 cell transplantation enhances testosterone production and Leydig cell regeneration in ethylene dimethanesulfonate (EDS)-treated and aged mice.</title><p>(<bold>A</bold>) Schematic illustrating the experimental design for Cd34-MC1 cell transplantation in EDS-treated mice. (<bold>B</bold>) Representative histological analysis by hematoxylin and eosin staining of testis sections showing structural restoration post-transplantation of Cd34-MC1 cells. Scale bar: 100 µm. (<bold>C</bold>) Immunofluorescence images confirming an increased presence of Leydig cells marked by Hsd3b1 expression in the testicular interstitium following Cd34-MC1 cell transplantation. Scale bar: 50 µm. (<bold>D</bold>) Serum testosterone levels measured at indicated time points post-EDS treatment demonstrating significant restoration following Cd34-MC1 transplantation. Data are presented as mean ± SEM. *p &lt; 0.05 compared to EDS-treated controls, <italic>n</italic> = 6. (<bold>E</bold>) Improved sperm progressive motility (PR) observed at day 20 post-transplantation compared to controls. Data presented as mean ± SEM. *p &lt; 0.05; **p &lt; 0.01 compared to EDS-treated group, <italic>n</italic> = 6. (<bold>F</bold>) Experimental schematic depicting Cd34-MC1-tdTomato cell transplantation into testes of <italic>Lhcgr</italic><sup>−/−</sup> mice. (<bold>G</bold>) Immunofluorescence images illustrating successful engraftment and differentiation of Cd34-MC1-tdTomato cells into Lhcgr<sup>+</sup> and Hsd3b1<sup>+</sup> Leydig cells within the interstitium of <italic>Lhcgr</italic><sup>−/−</sup> mouse testes. Data are presented as mean ± SEM. *p &lt; 0.05, <italic>n</italic> = 3, Scale bar: 50 µm. (<bold>H</bold>) Immunofluorescence comparison of Leydig cell regeneration capability between Cd34-MC1 (2-week-old) and Cd34-MC3 (24-month-old) transplanted cells, indicating a superior regenerative potential of younger progenitor cells. Scale bar: 50 µm. (<bold>I</bold>) Quantitative analysis revealing significantly fewer Hsd3b1-positive Leydig cells derived from transplanted Cd34-MC3 compared to Cd34-MC1 cells in <italic>Lhcgr</italic><sup>−/−</sup> mouse testes. Data are presented as mean ± SEM. *p &lt; 0.05, <italic>n</italic> = 3. (<bold>J</bold>) Statistical analysis comparing serum testosterone levels in Cd34-MC1-transplanted <italic>Lhcgr</italic><sup>−/−</sup> mice with or without human chorionic gonadotropin (hCG) treatment. Data are presented as mean ± SEM. *p &lt; 0.05, <italic>n</italic> = 3.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100396-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Restoration of testicular function by transplantation of Cd34-MC1 in Leydig cell (LC)-disrupted mouse models.</title><p>(<bold>A</bold>) Bright-field microscopy images showing clonal sphere formation capacity of Cd34-MC1 and Cd34-MC2 cells derived from single cells. Scale bar: 10 µm. (<bold>B</bold>) Immunofluorescence staining showing the differentiation of Cd34-MC1 and Cd34-MC2 into LCs, marked by LC-specific marker expression. (<bold>C</bold>) Flow cytometry results showing the percentage of Cd34<sup>+</sup>/Cd36<sup>-</sup> (CD34-MC1) cells in the testes of 3-week-old mice. (<bold>D</bold>) Quantification of seminiferous tubule diameter in the two groups. Three sections per slide and three slides per mouse testis were counted. Data are presented as the mean ± SEM. *, <italic>p</italic> &lt; 0.05; **, <italic>p</italic> &lt; 0.01; ***, <italic>p</italic> &lt; 0.001 (compared to the control group, n = 6). (<bold>E</bold>) Quantification of the number of Hsd3b1<sup>+</sup> cells in the three groups. Data are presented as the mean ± SEM. ***, <italic>p</italic> &lt; 0.001 (compared to the EDS-treated group, n = 6). (<bold>F</bold>) Immunofluorescence imaging with anti-Sycp3 antibody to identify meiotic spermatocytes in the testes. (<bold>G</bold>) Quantification showing a marked increase in Sycp3<sup>+</sup> seminiferous tubules per section in Cd34-MC1-transplanted mice versus those receiving EDS treatment only. (<bold>H</bold>) Evaluation of sperm motility differences between Cd34-MC1-transplanted mice and their non-transplanted counterparts. (<bold>I</bold>) Comparative imagery of tdTomato-leaky mice against standard inducible tdTomato mice (uninduced). (<bold>J</bold>) FACS-based isolation of Cd34-MC1 cells from 2-week-old tdTomato-leaky mice for subsequent transplantation. (<bold>K</bold>) Flow cytometry assessment revealing the presence of tdTomato<sup>+</sup> cells in the testes of Lhcgr knockout mice. (<bold>L</bold>) Flow cytometry showing the proportion of Cd34<sup>+</sup> MCs, and the immunofluorescence staining was performed to assess expression of Sox4 in sorted Cd34<sup>+</sup> cells in 3-week-old and 24-week-old groups.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100396-fig4-figsupp1-v2.tif"/></fig></fig-group><p>Importantly, Cd34-MC1 transplantation significantly restored serum testosterone levels between days 8 and 16 following EDS treatment (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Given testosterone’s crucial role in meiosis and spermatogenesis, we analyzed meiotic progression by immunostaining for the meiotic factor Sycp3. A pronounced increase in Sycp3-positive germ cells was observed in testes receiving Cd34-MC1 transplantation compared to the EDS-only controls (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1F, G</xref>). Additionally, progressive sperm motility significantly improved in the transplantation group assessed on day 20 (<xref ref-type="fig" rid="fig4">Figure 4E</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1H</xref>).</p><p>To further confirm the progenitor role of Cd34-MC1 cells in LC regeneration, we employed lineage-tracing experiments utilizing inducible tdTomato-expressing mice crossed with <italic>Lhcgr</italic> knockout (<italic>Lhcgr</italic><sup>−/−</sup>) mice, which exhibit impaired LC development. Due to occasional leaky tdTomato expression, Tomato<sup>high</sup> Cd34-MC cells from testes of both young (MC1) and aged (MC3) tdTomato reporter mice were collected through FACS-based isolation (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1I, J</xref>). These sorted cells were subsequently transplanted into the testes of 1-month-old <italic>Lhcgr</italic><sup>−/−</sup> recipient mice (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). After 3 weeks, a substantial number of tdTomato-positive LCs expressing both Hsd3b1 and Lhcgr were detected in the testes of mice transplanted with Cd34-MC1 cells (<xref ref-type="fig" rid="fig4">Figure 4G</xref>). In contrast, aged Cd34-MC3 cells failed to significantly contribute to LC regeneration, as evidenced by the absence of tdTomato-labeled <italic>Hsd3b1</italic>-expressing cells in recipient testes (<xref ref-type="fig" rid="fig4">Figure 4H, I</xref>; <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1K, L</xref>). Furthermore, serum testosterone levels significantly increased only in mice receiving Cd34-MC1 cells, underscoring their distinct regenerative and functional superiority compared to aged Cd34-MC3 progenitors (<xref ref-type="fig" rid="fig4">Figure 4J</xref>). These findings clearly establish Cd34-MC1 cells as potent LC progenitors capable of effective testicular regeneration and functional recovery.</p></sec><sec id="s2-5"><title>Identifying Sox4 as a key transcription factor maintaining stemness in Cd34-MC1 cells</title><p>H3K27ac ChIP-seq analysis further identified specific super-enhancers associated with critical transcription factors, notably Sox4, within Cd34-MC1 cells (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). GO analysis revealed that super-enhancers in Cd34-MC1 cells were significantly enriched for terms related to stem cell development (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). GSEA further underscored Sox4’s pivotal role in maintaining the stemness characteristics of Cd34-MC1 cells (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). Importantly, <italic>Sox4</italic> exhibited elevated expression during the early postnatal stage, which markedly declined throughout development (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). Consistently, H3K27ac levels at the <italic>Sox4</italic> locus progressively decreased from Cd34-MC1 to Cd34-MC2/3 subpopulations (<xref ref-type="fig" rid="fig5">Figure 5E</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>SE landscape reveals Sox4 as a crucial transcription factor in maintaining stemness in Cd34-MC1.</title><p>(<bold>A</bold>) Venn diagram illustrating Cd34-MC1-specific SEs compared with other Cd34-MC subtypes. (<bold>B</bold>) Gene Ontology (GO) enrichment analysis of SE-associated genes in three distinct Cd34-MC subpopulations. (<bold>C</bold>) Gene set enrichment analysis (GSEA) demonstrating significant enrichment of Sox4-regulated genes in pathways essential for maintaining stem cell populations. (<bold>D</bold>) Violin plots showing <italic>Sox4</italic> expression levels across distinct Cd34-MC subsets. (<bold>E</bold>) ChIP-seq profiles highlight H3K27ac mark enrichment at the <italic>Sox4</italic> locus within Cd34-MC1, Cd34-MC2, and Cd34-MC3. (<bold>F</bold>) Immunofluorescence images confirming successful <italic>Sox4</italic> knockdown (green, <italic>Sox4</italic> shRNA) in Cd34-MC1 cells, co-labeled with <italic>Sox4</italic> (purple) and Leydig cell marker Hsd3b1 (red), after 48 hr of shRNA-mediated <italic>Sox4</italic> suppression. Scale bar: 50 µm. Statistical significance indicated as *p &lt; 0.05; **p &lt; 0.01; ***p &lt; 0.001, <italic>n</italic> = 3. (<bold>G</bold>) qPCR analysis evaluating LC gene expression changes following 48 hr of <italic>Sox4</italic> knockdown in Cd34-MC1 cells. *p &lt; 0.05; **p &lt; 0.01; ***p &lt; 0.001, <italic>n</italic> = 3. (<bold>H</bold>) Schematic depicting transplantation of Cd34-MC1 cells with or without <italic>Sox4</italic> knockdown into <italic>Lhcgr</italic><sup>−/−</sup> mice. (<bold>I</bold>) Immunofluorescence staining demonstrating reduced numbers of Hsd3b1-positive Leydig cells derived from <italic>Sox4</italic>-knockdown <italic>Cd34</italic>-MC1 cells compared to controls in <italic>Lhcgr<sup>−</sup></italic><sup>/−</sup> mouse testes. Scale bar: 50 µm, <italic>n</italic> = 3. (<bold>J</bold>) Summary diagram illustrating the key findings of this research.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100396-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Construction of Sox4 and Cd34 knockdown Cd34-MC1.</title><p>(<bold>a</bold>) qPCR analysis showing the knockdown efficiency of Sox4 shRNAs in Cd34-MC1 cells. Statistical significance indicated as *p &lt; 0.05; **p &lt; 0.01; ***p &lt; 0.001, <italic>n</italic> = 3. (<bold>b</bold>) Fluorescence showing the infection efficiency of Sox4 shRNA lentiviruses in Cd34-MC1 cells. (<bold>c</bold>) qPCR analysis demonstrating the knockdown efficiency of Cd34 shRNAs in Cd34-MC1 cells. Statistical significance indicated as *p &lt; 0.05; **p &lt; 0.01; ***p &lt; 0.001, <italic>n</italic> = 3. (<bold>d</bold>) Fluorescence showing the infection efficiency of Cd34 shRNA lentiviruses in Cd34-MC1 cells. (<bold>e</bold>) qPCR analysis revealing altered Leydig cell gene expression 48 hours after Cd34 knockdown in Cd34-MC1 cells. Statistical significance indicated as *p &lt; 0.05; **p &lt; 0.01; ***p &lt; 0.001, <italic>n</italic> = 3.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-100396-fig5-figsupp1-v2.tif"/></fig></fig-group><p>To investigate the functional significance of Sox4, we utilized shRNA-mediated knockdown to suppress <italic>Sox4</italic> expression in primary Cd34-MC1 cells (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A, B</xref>). <italic>Sox4</italic> knockdown significantly increased the proportion of Hsd3b1-positive cells after 48 hr in culture (<xref ref-type="fig" rid="fig5">Figure 5F</xref>). Quantitative PCR (qPCR) analysis of key steroidogenic pathway genes demonstrated that <italic>Sox4</italic> knockdown notably upregulated expression of <italic>Lhcgr</italic>, <italic>Hsd3b1</italic>, <italic>Star</italic>, <italic>Cyp17a1</italic>, and <italic>Cyp11a1</italic> (<xref ref-type="fig" rid="fig5">Figure 5G</xref>). Additionally, targeting <italic>Cd34</italic> with shRNA lentivirus resulted in increased expression of <italic>Lhcgr</italic> and <italic>Cyp17a1</italic> but decreased expression of <italic>Hsd3b1</italic>, <italic>Star</italic>, and <italic>Cyp11a1</italic> in Cd34-MC1 cells (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C–E</xref>). These results suggest that Cd34 is dispensable for maintaining stemness and differentiation potential in these cells.</p><p>To further validate Sox4’s role in vivo, we injected <italic>Sox4</italic> knockdown or control Cd34-MC1 cells into 1-month-old <italic>Lhcgr</italic><sup>−/−</sup> mice (<xref ref-type="fig" rid="fig5">Figure 5H</xref>). Three weeks post-injection, a substantial increase in LCs has been observed, identified by Hsd3b1 expression, within the testicular interstitium in the <italic>Sox4</italic> knockdown group (<xref ref-type="fig" rid="fig5">Figure 5I</xref>). Collectively, these findings highlight Sox4 as an essential transcription factor for maintaining stem cell identity in Cd34<sup>+</sup>/Sox4<sup>+</sup> MC1 cells.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>The primary goal of this study was to elucidate the cellular dynamics of the testicular interstitium across the male lifespan, with a particular focus on identifying progenitor cells that maintain and regenerate the LC population. Single-cell transcriptomic analysis and complementary functional experiments demonstrated that Cd34<sup>+</sup>/Sox4<sup>+</sup> mesenchymal cells constitute a pivotal progenitor source for LC maintenance and regeneration (<xref ref-type="fig" rid="fig5">Figure 5J</xref>). Our data show that these cells give rise to adult LCs, and they exhibit remarkable regenerative properties: they form stem cell spheres in culture and readily differentiate into testosterone-producing LCs. When transplanted into models of LC loss or dysfunction, Cd34<sup>+</sup>/Sox4<sup>+</sup> cells efficiently colonized the interstitial niche and restored LC numbers and function. These findings establish Cd34<sup>+</sup>/Sox4<sup>+</sup> mesenchymal cells as a novel stem/progenitor population dedicated to supporting the LC compartment in the testis.</p><p>Notably, Cd34<sup>+</sup>/Sox4<sup>+</sup> progenitors predominantly reside in peritubular regions of the testis during the neonatal period, and their frequency diminishes as the organism matures. This observation aligns with the idea that the early postnatal testis harbors a rich pool of stem-like interstitial cells that gradually become depleted or quiescent in adulthood. Previous reports have described CD34-positive interstitial cells in the testis (<xref ref-type="bibr" rid="bib15">Kuroda et al., 2004</xref>), including CD34<sup>+</sup>PDGFRα<sup>+</sup> telocytes that form intricate networks connecting LCs, peritubular myoid cells, and blood vessels (<xref ref-type="bibr" rid="bib1">Abe, 2022</xref>). These telocyte-like cells express adhesion molecules (integrins α4/α9/β1) and VCAM1, suggesting they help create a niche conducive to LC development. However, the precise role of CD34<sup>+</sup> cells in adult testis physiology has not been fully clear. Our findings refine this concept by identifying Cd34<sup>+</sup>/Sox4<sup>+</sup> cells as an active subset within this interstitial network that contributes to LC maintenance and regeneration, while exhibiting transcriptional overlap with previously described progenitor populations such as Pdgfra<sup>+</sup>, Arx<sup>+</sup>, and Tcf21<sup>+</sup> cells. In neonatal testes, they actively contribute to the expanding LC population, and even in adults, a residual subset retains the capacity to regenerate LCs under the right conditions. The involvement of Sox4 as a key transcriptional regulator in these cells is a unique feature of this progenitor population, hinting at specific molecular programs that endow them with stemness and differentiation potential.</p><p>The identification of Cd34<sup>+</sup>/Sox4<sup>+</sup> mesenchymal cells thus complements and extends current models of Leydig progenitor biology, integrating them into a broader framework of interstitial progenitors that collectively sustain LC renewal. For example, Nestin-positive interstitial cells were earlier proposed as stem LCs in the rodent testis (<xref ref-type="bibr" rid="bib12">Jiang et al., 2014</xref>), and CD51 (integrin α_v) has been used as a surface marker to isolate stem LCs that can self-renew and give rise to LCs (<xref ref-type="bibr" rid="bib33">Zang et al., 2017</xref>). Transplantation of CD51<sup>+</sup> cells in testosterone-deficient animal models resulted in the differentiation of these cells into mature LCs and partial recovery of testicular function (<xref ref-type="bibr" rid="bib33">Zang et al., 2017</xref>). More recently, lineage-tracing studies of <italic>Tcf21</italic>-expressing interstitial cells provided evidence for a bipotential somatic progenitor that can generate both LCs and peritubular myoid cells in adult mice (<xref ref-type="bibr" rid="bib23">Shen et al., 2021</xref>). Within this context, Cd34<sup>+</sup>/Sox4<sup>+</sup> progenitors represent one subset of this coordinated network, defined by a distinctive transcriptional profile (including Sox4 expression) identified through unbiased single-cell profiling. They emerge prominently during early postnatal development and exhibit robust regenerative capacity when transplanted into LC-depleted testes. Their identification and characterization, therefore, enhance rather than replace existing progenitor models and underscore the cooperative nature of multiple progenitor populations in maintaining LC homeostasis. Although FACS-based solely on CD34 enrichment yields a mixed population (~50% purity of Cd34-MC1), our marker validation (Sox4 immunostaining) and consistent regenerative results support Cd34-MC1 as the primary driver of the observed functional effects.</p><p>In addition to defining this progenitor population, single-cell atlas captured the broader heterogeneity of interstitial cells and revealed other noteworthy cell types in the testis. For instance, unsupervised clustering identified an AC population co-expressing markers of LCs (e.g., Hsd3b1) and macrophages (F4/80). This hybrid expression profile hints that ACs may represent an intermediate or transitional state with immunological functions in the testis. Interestingly, similar hybrid or fusion-like macrophage-derived cells have been documented in other tissues. In tumors and regenerating liver, macrophages can fuse with epithelial cells, forming hybrids with dual identities. In fibrotic organs, macrophages can transdifferentiate into collagen-producing myofibroblasts (MMT), contributing to tissue remodeling. Notably, testicular macrophages themselves have been shown to express steroidogenic enzymes and participate in androgen biosynthesis. These precedents support the plausibility that macrophages can adopt tissue-specific programs. Thus, the AC population observed here may reflect a functionally specialized, macrophage-derived subset involved in testicular immune–endocrine crosstalk.</p><p>We explicitly compared our findings with recent scRNA-seq analyses of testicular aging, such as the study by <xref ref-type="bibr" rid="bib34">Zhang et al., 2023</xref>. Consistent with their observations, we identified aging-associated inflammation, oxidative stress, and reduced steroidogenesis in LCs. Our study significantly expands these findings by analyzing multiple developmental stages across the lifespan and by functionally validating the Cd34<sup>+</sup>/Sox4<sup>+</sup> mesenchymal progenitors, directly linking their decline to impaired LC regeneration during aging.</p><p>Finally, integrative analysis shed light on how age-related changes in the testicular microenvironment might influence LC function and the activity of progenitor cells. Single-cell analysis observed signs of increasing oxidative stress in the aging testis, such as reduced antioxidant gene expression in older LCs and lower glutathione levels, consistent with reports that aged LCs produce more reactive oxygen species and have diminished antioxidant defenses. Notably, the antioxidant regulator Nrf2 was found to be under super-enhancer control in Cd34<sup>+</sup> progenitor cells, yet its expression declined in mature LCs with age. This suggests that young Cd34<sup>+</sup>/Sox4<sup>+</sup> mesenchymal cells may help maintain a redox-balanced niche which is lost as the cells (and Nrf2 activity) wane over time, potentially contributing to the age-associated drop in testosterone production. In parallel, we found that testicular macrophages likely play a supportive role in LC development early in life but may become detrimental with aging. Prepubertal macrophages secrete factors (e.g., Vcam1, Igf1) that support LC differentiation, whereas aging macrophages adopt an immunosuppressive, pro-inflammatory phenotype and can produce excess ROS. Such changes in macrophages could impair Cd34<sup>+</sup>/Sox4<sup>+</sup> progenitor differentiation and hinder LC steroidogenesis in older animals. Together, these insights emphasize that a healthy metabolic and immune environment is important for optimal function of LCs and their progenitors. We have de-emphasized these metabolic and macrophage findings in our interpretation to keep the spotlight on the progenitor cells; however, they provide important context for how systemic aging might modulate the effectiveness of the LC regenerative process.</p><p>In summary, this study provides a high-resolution atlas of the murine testicular interstitium across postnatal development and aging, uncovering a novel Cd34<sup>+</sup>/Sox4<sup>+</sup> mesenchymal cell population that serves as LC progenitors. By delineating previously unappreciated cell types and their interactions, we highlight the critical importance of cellular diversity in the maintenance of testicular function. The discovery of a dedicated LC progenitor pool opens new avenues for understanding testis aging and for developing regenerative therapies. Our findings not only advance fundamental knowledge of how the adult LC population is sustained but also pave the way toward cell-based interventions for conditions such as age-related hypogonadism and other forms of testosterone deficiency.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Animals</title><p>Wild-type C57BL/6J mice, Lhcgr knock-out mice in C57BL/6J background and Rosa26-CAG-loxp-stop-loxp-tdTomato mice were used in this study. The wild-type C57BL/6J mice were purchased from GemPharmatech, China, the Lhcgr knockout mice were donated by Zhenmin Lei’s laboratory, and the Rosa26-CAG-loxp-stop-loxp-tdTomato mice were donated by Zhao Meng’s laboratory.</p></sec><sec id="s4-2"><title>Isolation and capture of mouse testicular interstitial cells</title><p>Testis samples from C57BL/6J mice were dissected aseptically, and the tunica albuginea was carefully removed to enrich interstitial cells, as previously described. The interstitial compartment was then gently dissociated using collagenase type IV (1 mg/ml in DMEM-F12, phenol red-free) at 37°C for 10 min, preserving the seminiferous tubule structure intact. During digestion, tissues were gently pipetted up and down to achieve optimal dissociation while maintaining cell viability. Digestion was halted by adding 2% FBS, and the cell suspension was filtered through a 40-μm nylon mesh to remove tissue debris, followed by gentle red blood cell lysis. Cells were centrifuged (350 rcf, 5 min, room temperature) and resuspended in DPBS or 2% FBS in DPBS.</p></sec><sec id="s4-3"><title>Flow cytometry analysis and cell sorting</title><p>For single-cell transcriptional profiling, the interstitial cells were suspended in DPBS containing 2% FBS and loaded onto a FACSAria III instrument for FACS. After sorting, the interstitial cells were selected for the construction of a single-cell RNA-sequencing library.</p><p>To identify markers and for cell culture experiments, testicular cells obtained after collagenase dissection were suspended in DPBS. The cells were incubated with primary antibodies, specifically Cd34-PE /Cd34-FITC and Cd36-APC, at 4°C for 30 min to facilitate marker identification. To minimize fluorescence quenching, the samples were protected from light during this process. The unbound antibodies were removed by washing with DPBS containing 2% FBS. Subsequently, the cells were centrifuged at 350 rcf for 5 min at room temperature and re-suspended in DPBS containing 2% FBS for flow cytometry analysis and cell sorting.</p></sec><sec id="s4-4"><title>Clonal sphere formation assay for Cd34-MC1</title><p>Cd34<sup>+</sup> cells were diluted to a density of 100 cells/ml and seeded into ultra-low adherent 96-well plates at a volume of 10 µl per well. A total of 150 µl of medium was added to each well. The medium consisted of DMEM/F12 supplemented with 5% chicken embryo extract, 1 nM dexamethasone, 1% ITS, 1% non-essential amino acids, 1% N2 and 2% B27 supplements, 0.1 mM β-mercaptoethanol, and 1 ng/ml LIF, 20 ng/ml bFGF, 10 ng/ml EGF, 20 ng/ml PDGF-BB, and oncostatin-M.</p><p>Wells containing only one cell were marked, and the cultures were observed daily. Spheres were identified as free-floating spherical structures with a diameter greater than 50 µm. The cultures were maintained in a 5% CO2 water-jacketed incubator at 37°C, and the medium was changed every 3 days.</p></sec><sec id="s4-5"><title>Cell differentiation culture</title><p>To initiate cell differentiation, 20,000 Cd34<sup>+</sup> cells were suspended in a medium and plated on gelatin-coated glass-bottom cell culture dishes. The medium used was composed of phenol red-free DMEM/F12 supplemented with 2% FBS, 10 ng/ml PDGF-BB, 1 ng/ml LH, 1 nM TH, 70 ng/ml IGF1, and 1% ITS supplement.</p><p>The cells were incubated at 37°C in a 5% CO2 environment for 3 days. Proliferation of the cells was assessed using the Click-iT Edu imaging kit, following the manufacturer’s instructions. Subsequently, differentiation was confirmed by immunostaining for lineage-specific markers of LCs.</p></sec><sec id="s4-6"><title>Cd34-MC1 cell transplantation</title><p>Ninety male C57BL/6J mice aged 3 months and ten male C57BL/6J mice aged 24 months were included in this study. The 3-month-old mice were randomly divided into three groups: Control group, EDS injury group, and Cell transplantation group (<italic>n</italic> = 5 for each group at each time point). The control group received an intraperitoneal injection of DPBS, while the other two groups received a single dose of 200 mg/kg body weight of EDS, which led to the depletion of LCs in the adult testis within 4–6 days.</p><p>To assess whether the injection of Cd34<sup>+</sup> cells could facilitate the recovery of LC dysfunction, the Cd34<sup>+</sup> cells were washed with DPBS, approximately 20,000 Cd34<sup>+</sup> cells in 10 µl of PBS were injected into the parenchyma of the recipient testes 4 days after the 3-month-old mice had received EDS treatment. Testes and serum samples from all animals were collected at 0, 4, 8, 12, 16, and 20 days after EDS treatment for subsequent flow cytometry analysis, histological analysis, and measurement of testosterone concentration.</p></sec><sec id="s4-7"><title>Cd34-MC-tdTomato cell transplantation</title><p>Cd34-MC-tdTomato cells were isolated from the testes of about 2 weeks (Cd34-MC1) and 24 months (Cd34-MC3) male tdTomato-leaky Rosa26-CAG-loxp-stop-loxp-tdTomato mice using flow cytometry. These isolated cells were then resuspended in DPBS. Subsequently, we performed orthotopic transplantations into the C57BL/6J <italic>Lhcgr<sup>−/−</sup></italic> mice. The right testis tissue of each C57BL/6J <italic>Lhcgr<sup>−/−</sup></italic> mouse received an injection of 80,000 Cd34-MC-tdTomato cells in a volume of 10 μl per tissue, while the left testis tissue received a control injection of 10 μl of DPBS. After a 3-week period, we collected testes from six of the mice that had undergone cell transplantation for immunofluorescence staining.</p></sec><sec id="s4-8"><title>Testosterone concentration assay</title><p>At each specified time point of EDS model, mouse sera were collected for quantitative measurement of testosterone levels. To evaluate hypothalamic–pituitary–gonadal axis regulation, mice received an intraperitoneal injection of human chorionic gonadotropin (10 IU) prior to serum collection to stimulate testosterone production. Testosterone concentrations were subsequently measured using a commercially available ELISA kit according to the manufacturer’s instructions.</p></sec><sec id="s4-9"><title><italic>Sox4</italic>-shRNA infection and assessment</title><p>We constructed shRNA sequences targeting <italic>Sox4</italic> or <italic>Cd34</italic> and integrated them into the pTSBX-U6-shRNA-EF1-copGFP-2A-PURO lentiviral vector. Flow cytometry was utilized to sort Cd34-MC1 cells, which were then infected with lentiviruses carrying specific shRNA for 12 hr. After the infection period, cells were cultured in fresh medium for up to 48 hr. The efficiency of gene silencing was assessed using quantitative PCR (qPCR). The shRNAs and primers used in this paper are provided in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>.</p></sec><sec id="s4-10"><title>Immunofluorescence of the mouse testis</title><p>Immunofluorescence staining was performed on 5 μm formalin-fixed, paraffin-embedded sections from testis samples. Sections were rehydrated and subjected to heat-mediated antigen retrieval in 10 mM sodium citrate buffer (pH 6.0). After blocking with goat serum working solution for 30 min, sections were incubated overnight at 4°C with a mix of diluted primary antibodies at their recommended dilutions. Antigen detection was conducted using Alexa Fluor 488 (Thermo Fisher Scientific, A11034, A11029) and Alexa Fluor 594 (Thermo Fisher Scientific, A11032, A11037) secondary antibodies (1:500) for 2 hr at room temperature in the dark. All primary and secondary antibodies were diluted in 0.5% BSA. After three washes in PBS, sections were counterstained with Hoechst 33342 (1:2000 in PBS) to visualize nuclei. Images were captured using a Zeiss LSM780 Confocal Laser Scanning Microscope with 20x or 63x oil immersion objectives and analyzed using ZEN software. The primary and secondary antibodies used in this study are listed in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>.</p></sec><sec id="s4-11"><title>Histological examination</title><p>Testes were dissected from mice, fixed in 4% paraformaldehyde for 12 hr at 4°C, embedded in paraffin, and sectioned into 5 μm slices. Before staining, tissue sections were dewaxed in xylene, rehydrated through a series of decreasing ethanol concentrations, and washed in distilled water. Sections were stained with hematoxylin and eosin, dehydrated through increasing ethanol concentrations, cleared in xylene, and mounted with neutral balsam. Stained sections were examined using an Olympus BX63 microscope.</p></sec><sec id="s4-12"><title>Cut&amp;Tag library construction</title><p>CUT&amp;Tag for profiling histone H3K27ac was performed using the Hyperactive Universal CUT&amp;Tag Assay Kit for Illumina (Vazyme, TD903-02), and anti-H3K27ac antibodies were used to enrich target DNA fragments from Cd34-MC1, MC2, and MC3 cells obtained by flow sorting. TruePrep Index Kit for Illumina (v21.2, Vazyme, TD202) was used for DNA library construction.</p></sec><sec id="s4-13"><title>Data analysis of Cut&amp;Tag</title><p>For H3K27ac-CUT&amp;Tag data, clean reads were aligned to the <italic>Mus musculus</italic> reference genome (mm9) using Bowtie2 software (v2.4.0). Duplicated reads were removed, and only uniquely mapping reads were retained for further analysis. MACS2 (v2.1.1) was used to call peaks using the parameters -p 0.05. For broad peaks, H3K27ac signal intensity from CUT&amp;Tag data was used to define SEs. SEs were identified and annotated using the default parameters -t 2500, following the ROSE algorithm (<xref ref-type="bibr" rid="bib30">Whyte et al., 2013</xref>). BigWig files were visualized using IGV (v2.16.0), and heatmaps and signal profiles were generated using deepTools.</p></sec><sec id="s4-14"><title>Quantitative real-time PCR</title><p>Total RNA was extracted from the cells using TRIzol reagent, following the manufacturer’s instructions. The concentration and purity of RNA were assessed using a NanoDrop spectrophotometer. Complementary DNA (cDNA) was synthesized from 1 μg of total RNA using the High-Capacity cDNA Reverse Transcription Kit. Quantitative real-time PCR was performed using the SYBR Green PCR Master Mix on the QuantStudio 5 Real-Time PCR System. The thermal cycling conditions were 95°C for 10 min, followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. Gene expression levels were normalized to GAPDH and calculated using the 2<sup>−ΔΔCt</sup> method. Each sample was analyzed in triplicate.</p></sec><sec id="s4-15"><title>Processing of scRNA-seq data</title><p>scRNA-seq data of testicular samples were aligned and quantified using the Cell Ranger Software Suite (v3.0.2, 10X Genomics). Approximately 7000–120,000 cells per sample were captured. The reads were aligned to the <italic>M. musculus</italic> reference genome (mm10), and after alignment, filtering, barcode counting, and UMI counting using the Cell Ranger pipeline, feature-barcode matrices were generated.</p><p>Quality control was performed using the Seurat R package (v4.0) (<xref ref-type="bibr" rid="bib10">Hao et al., 2021</xref>; <xref ref-type="bibr" rid="bib21">Qiu et al., 2017</xref>). Cells expressing fewer than 300 genes or more than 6000 genes as well as more than 40,000 counts were excluded to avoid empty droplets and doublets. Genes expressed in fewer than 20 cells were also removed from analysis. Additionally, cells with &gt;25% mitochondrial gene content were excluded to remove dead or damaged cells.</p><p>To further ensure data quality, doublet detection was explicitly performed using the DoubletFinder package and removed according to their barcodes. Only high-quality singlets were retained for subsequent analysis.</p><p>To correct for batch effects, we used the FindIntegrationAnchors function in Seurat (v4.0) (<xref ref-type="bibr" rid="bib26">Stuart et al., 2019</xref>) to integrate data across different samples. We also applied another batch correction method, Harmony, to correct for batch effects and obtain consistent clustering results. The FindClusters function with a resolution of 0.25 was used to identify 17 distinct cell clusters, and FindMarkers was used to determine DEGs and identify marker genes for each cell type.</p></sec><sec id="s4-16"><title>Cell type identification and definition</title><p>Single-cell transcriptomic analysis enabled the identification of distinct interstitial cell populations:</p><p>Mesenchymal cells (MCs) were defined as multipotent stromal interstitial cells, following classical descriptions (<xref ref-type="bibr" rid="bib22">Roberts and Skinner, 1990</xref>), further characterized as stromal niche-supporting cells (<xref ref-type="bibr" rid="bib14">Kfoury and Scadden, 2015</xref>).</p><p>LCs were identified by their steroidogenic marker expression and classified based on developmental lineage definitions established previously (<xref ref-type="bibr" rid="bib3">Chen et al., 2009</xref>).</p><p>Progenitor-like cells (PLCs) were defined as early Leydig progenitors, exhibiting partial steroidogenic gene expression and proliferative capacity, consistent with prior descriptions of Leydig progenitors or stem LCs (<xref ref-type="bibr" rid="bib12">Jiang et al., 2014</xref>; <xref ref-type="bibr" rid="bib23">Shen et al., 2021</xref>; <xref ref-type="bibr" rid="bib23">Shen et al., 2021</xref>; <xref ref-type="bibr" rid="bib4">Chikhovskaya et al., 2014</xref>).</p></sec><sec id="s4-17"><title>Gene enrichment analysis</title><p>To identify the functions and crucial pathways of DEGs across the different cell types, the DEGs were analyzed by the ClusterProfiler package (v4.0.5) (<xref ref-type="bibr" rid="bib31">Wu et al., 2021</xref>; <xref ref-type="bibr" rid="bib32">Yu et al., 2012</xref>) through the GO, Kyoto Encyclopedia of Genes and Genomes, and GSEA databases. All the significantly enriched terms were determined using the p-value cutoff = 0.05, while the enrichment of GSEA terms also shows the normalized enrichment score, indicating statistical significance.</p></sec><sec id="s4-18"><title>Trajectory analysis</title><p>To investigate the temporal progression and developmental trajectories of LC and mesenchymal cell subtypes, we performed pseudotime analysis using Monocle (v2.20.0) (<xref ref-type="bibr" rid="bib28">Trapnell et al., 2014</xref>). This analysis was conducted based on the expression patterns of highly variable genes that were identified by Seurat. Pseudotime represents a continuous trajectory that captures the inferred developmental progression of individual cells within a population.</p></sec><sec id="s4-19"><title>Definition of functional scores</title><p>In order to evaluate the functional characteristics of testicular macrophages at different stages of postnatal development, we employed the ‘AddModuleScore’ function within Seurat to calculate functional scores for specific gene sets of interest. These gene sets were chosen based on their relevance to macrophage biology and included the following functional categories: macrophage migration (GO:1905517), antigen processing and presentation (GO:0019882), phagocytosis (GO:0006909), and macrophage cytokine production (GO:0010934). Additionally, we incorporated M1/M2 polarization gene sets, which were obtained from a previously published study (<xref ref-type="bibr" rid="bib27">Sun et al., 2021</xref>).</p></sec><sec id="s4-20"><title>Cell–cell interaction analysis</title><p>To investigate cell–cell interactions within the mouse testis, we utilized the CellChat software (v1.1.2) (<xref ref-type="bibr" rid="bib13">Jin et al., 2021</xref>). Several functions within CellChat were employed to analyze and visualize the signaling pathways involved in cell–cell communication. First, we utilized the ‘netVisual_chord_gene’ function to visualize the signaling pathways originating from macrophages and targeting LCs or Cd34<sup>+</sup> mesenchymal cells. This allowed us to explore the interactions and potential signaling events between these cell types. Next, the ‘netVisual_aggregate’ function was employed to display selected signaling networks related to the signaling pathways of interest. This function enabled us to focus on specific signaling pathways and investigate the interactions between different cell populations within the testis. Furthermore, the ‘netVisual_bubble’ function was utilized to present specific ligand–receptor pairs associated with the signaling pathways of interest. Ligand–receptor pairs such as VCAM, IGF, VISFATIN, and GAS signaling pathways were specifically examined, providing insights into the potential molecular interactions and communication between cells involved in these pathways.</p></sec><sec id="s4-21"><title>Statistical analysis</title><p>Quantitative results are presented as mean ± SEM. ANOVA was used for multiple comparisons; where significance was detected, post hoc testing was then carried out (GraphPad Prism). All other quantitative analyses were analyzed using unpaired Student’s <italic>t</italic>-tests. Statistical analyses are indicated in figure legends. Significant outliers were detected using Grubb’s test (GraphPad Prism). Significance was determined at p &lt; 0.05.</p></sec><sec id="s4-22"><title>Ethical approval statement</title><p>All mice used were housed and cared for in accordance with ethical guidelines, and experimental protocols were approved by the Ethics Committee of Sun Yat-sen University (No. 2017-133).</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Supervision, Validation, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Data curation, Methodology, Writing – original draft</p></fn><fn fn-type="con" id="con4"><p>Data curation, Software, Formal analysis</p></fn><fn fn-type="con" id="con5"><p>Supervision, Funding acquisition</p></fn><fn fn-type="con" id="con6"><p>Supervision, Funding acquisition</p></fn><fn fn-type="con" id="con7"><p>Supervision, Methodology</p></fn><fn fn-type="con" id="con8"><p>Supervision, Funding acquisition, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Supervision, Funding acquisition, Validation, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals. All of the animals were handled according to 'Regulations on the management of experimental animals' and 'Guidelines on the good treatment of laboratory animals' of the Sun Yat-sen University. The protocol was approved by the Committee on the Ethics of Animal Experiments of the Sun Yat-sen University (Permit Number: 2017-133). All surgery was performed under sodium pentobarbital anesthesia, and every effort was made to minimize suffering.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-100396-mdarchecklist1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>shRNAs and primers.</title></caption><media xlink:href="elife-100396-supp1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Primary and secondary antibodies.</title></caption><media xlink:href="elife-100396-supp2-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Chemicals, Peptides, and Recombinant Proteins.</title></caption><media xlink:href="elife-100396-supp3-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>Software and Algorithms.</title></caption><media xlink:href="elife-100396-supp4-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp5"><label>Supplementary file 5.</label><caption><title>Critical Commercial Assays.</title></caption><media xlink:href="elife-100396-supp5-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp6"><label>Supplementary file 6.</label><caption><title>Instrument and Equipments.</title></caption><media xlink:href="elife-100396-supp6-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Sequencing data have been deposited in GEO under accession codes GSE262415 and GSE262416. All data generated or analyzed during this study are included in the manuscript and supplemental information files. No new code has been generated for this manuscript, software used is cited in <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>.</p><p>The following datasets were generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Xia</surname><given-names>K</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Hong</surname><given-names>M</given-names></name><name><surname>Jiang</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Lei</surname><given-names>Z</given-names></name><name><surname>Xiang</surname><given-names>AP</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>A comprehensive atlas of testicular interstitium reveals Cd34+/Sox4+ mesenchymal cells as potential Leydig cell progenitors</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE262415">GSE262415</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset2"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Xia</surname><given-names>K</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Hong</surname><given-names>M</given-names></name><name><surname>Jiang</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Lei</surname><given-names>Z</given-names></name><name><surname>Xiang</surname><given-names>AP</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>A comprehensive atlas of testicular interstitium reveals Cd34+/Sox4+ mesenchymal cells as potential Leydig cell progenitors</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE262416">GSE262416</pub-id></element-citation></p><p>The following previously published dataset was used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset3"><person-group person-group-type="author"><name><surname>Sohni</surname><given-names>A</given-names></name><name><surname>Tan</surname><given-names>K</given-names></name><name><surname>Song</surname><given-names>HW</given-names></name><name><surname>Burow</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>Neonatal and adult human testis defined at the single-cell level</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE124263">GSE124263</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>This work was supported by the National Key Research and Development Program of China (2023YFC2506100 and 2017YFA0103800) and National Natural Science Foundation of China (82172698 and 82303201). The High-level Hospital Construction Project (DFJHBF202102).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abe</surname><given-names>SI</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Behavior and functional roles of CD34<sup>+</sup> mesenchymal cells in mammalian testes</article-title><source>International Journal of Molecular Sciences</source><volume>23</volume><elocation-id>9585</elocation-id><pub-id pub-id-type="doi">10.3390/ijms23179585</pub-id><pub-id pub-id-type="pmid">36076981</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chamindrani Mendis-Handagama</surname><given-names>SML</given-names></name><name><surname>Siril Ariyaratne</surname><given-names>HB</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Differentiation of the adult leydig cell population in the postnatal testis1</article-title><source>Biology of Reproduction</source><volume>65</volume><fpage>660</fpage><lpage>671</lpage><pub-id pub-id-type="doi">10.1095/biolreprod65.3.660</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Ge</surname><given-names>R-S</given-names></name><name><surname>Zirkin</surname><given-names>BR</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Leydig cells: From stem cells to aging</article-title><source>Molecular and Cellular Endocrinology</source><volume>306</volume><fpage>9</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1016/j.mce.2009.01.023</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chikhovskaya</surname><given-names>JV</given-names></name><name><surname>van Daalen</surname><given-names>SKM</given-names></name><name><surname>Korver</surname><given-names>CM</given-names></name><name><surname>Repping</surname><given-names>S</given-names></name><name><surname>van Pelt</surname><given-names>AMM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Mesenchymal origin of multipotent human testis-derived stem cells in human testicular cell cultures</article-title><source>MHR</source><volume>20</volume><fpage>155</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1093/molehr/gat076</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeFalco</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>S</given-names></name><name><surname>Capel</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Two distinct origins for Leydig cell progenitors in the fetal testis</article-title><source>Developmental Biology</source><volume>352</volume><fpage>14</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2011.01.011</pub-id><pub-id pub-id-type="pmid">21255566</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forest</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="1983">1983</year><article-title>Role of androgens in fetal and pubertal development</article-title><source>Hormone Research</source><volume>18</volume><fpage>69</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1159/000179780</pub-id><pub-id pub-id-type="pmid">6350147</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ge</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>Hardy</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="2008">2008</year><chapter-title>The role of the leydig cell in spermatogenic function</chapter-title><person-group person-group-type="editor"><name><surname>Cheng</surname><given-names>CY</given-names></name></person-group><source>Molecular Mechanisms in Spermatogenesis</source><publisher-loc>New York, NY</publisher-loc><publisher-name>Springer</publisher-name><fpage>255</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1007/978-0-387-09597-4_14</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haider</surname><given-names>SG</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Cell biology of leydig cells in the testis</article-title><source>In International Review of Cytology</source><volume>233</volume><fpage>181</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1016/S0074-7696(04)33005-6</pub-id><pub-id pub-id-type="pmid">15037365</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hameed</surname><given-names>W</given-names></name><name><surname>Yousaf</surname><given-names>I</given-names></name><name><surname>Latif</surname><given-names>R</given-names></name><name><surname>Aslam</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Effect of visfatin on testicular steroidogenesis in purified Leydig cells</article-title><source>Journal of Ayub Medical College, Abbottabad</source><volume>24</volume><fpage>62</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">24669612</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Hao</surname><given-names>S</given-names></name><name><surname>Andersen-Nissen</surname><given-names>E</given-names></name><name><surname>Mauck</surname><given-names>WM</given-names></name><name><surname>Zheng</surname><given-names>S</given-names></name><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>MJ</given-names></name><name><surname>Wilk</surname><given-names>AJ</given-names></name><name><surname>Darby</surname><given-names>C</given-names></name><name><surname>Zager</surname><given-names>M</given-names></name><name><surname>Hoffman</surname><given-names>P</given-names></name><name><surname>Stoeckius</surname><given-names>M</given-names></name><name><surname>Papalexi</surname><given-names>E</given-names></name><name><surname>Mimitou</surname><given-names>EP</given-names></name><name><surname>Jain</surname><given-names>J</given-names></name><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Stuart</surname><given-names>T</given-names></name><name><surname>Fleming</surname><given-names>LM</given-names></name><name><surname>Yeung</surname><given-names>B</given-names></name><name><surname>Rogers</surname><given-names>AJ</given-names></name><name><surname>McElrath</surname><given-names>JM</given-names></name><name><surname>Blish</surname><given-names>CA</given-names></name><name><surname>Gottardo</surname><given-names>R</given-names></name><name><surname>Smibert</surname><given-names>P</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Integrated analysis of multimodal single-cell data</article-title><source>Cell</source><volume>184</volume><fpage>3573</fpage><lpage>3587</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.04.048</pub-id><pub-id pub-id-type="pmid">34062119</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeremy</surname><given-names>M</given-names></name><name><surname>Gurusubramanian</surname><given-names>G</given-names></name><name><surname>Roy</surname><given-names>VK</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Localization pattern of visfatin (NAMPT) in d-galactose induced aged rat testis</article-title><source>Annals of Anatomy = Anatomischer Anzeiger</source><volume>211</volume><fpage>46</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/j.aanat.2017.01.009</pub-id><pub-id pub-id-type="pmid">28163205</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>MH</given-names></name><name><surname>Cai</surname><given-names>B</given-names></name><name><surname>Tuo</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Zang</surname><given-names>ZJ</given-names></name><name><surname>Tu</surname><given-names>X</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Su</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Jiao</surname><given-names>J</given-names></name><name><surname>Wan</surname><given-names>Z</given-names></name><name><surname>Deng</surname><given-names>C</given-names></name><name><surname>Lahn</surname><given-names>BT</given-names></name><name><surname>Xiang</surname><given-names>AP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Characterization of Nestin-positive stem Leydig cells as a potential source for the treatment of testicular Leydig cell dysfunction</article-title><source>Cell Research</source><volume>24</volume><fpage>1466</fpage><lpage>1485</lpage><pub-id pub-id-type="doi">10.1038/cr.2014.149</pub-id><pub-id pub-id-type="pmid">25418539</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>S</given-names></name><name><surname>Guerrero-Juarez</surname><given-names>CF</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Chang</surname><given-names>I</given-names></name><name><surname>Ramos</surname><given-names>R</given-names></name><name><surname>Kuan</surname><given-names>CH</given-names></name><name><surname>Myung</surname><given-names>P</given-names></name><name><surname>Plikus</surname><given-names>MV</given-names></name><name><surname>Nie</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Inference and analysis of cell-cell communication using CellChat</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>1088</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-21246-9</pub-id><pub-id pub-id-type="pmid">33597522</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kfoury</surname><given-names>Y</given-names></name><name><surname>Scadden</surname><given-names>DT</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mesenchymal cell contributions to the stem cell niche</article-title><source>Cell Stem Cell</source><volume>16</volume><fpage>239</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2015.02.019</pub-id><pub-id pub-id-type="pmid">25748931</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuroda</surname><given-names>N</given-names></name><name><surname>Nakayama</surname><given-names>H</given-names></name><name><surname>Miyazaki</surname><given-names>E</given-names></name><name><surname>Hayashi</surname><given-names>Y</given-names></name><name><surname>Toi</surname><given-names>M</given-names></name><name><surname>Hiroi</surname><given-names>M</given-names></name><name><surname>Enzan</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Distribution and role of CD34-positive stromal cells and myofibroblasts in human normal testicular stroma</article-title><source>Histology and Histopathology</source><volume>19</volume><fpage>743</fpage><lpage>751</lpage><pub-id pub-id-type="doi">10.14670/HH-19.743</pub-id><pub-id pub-id-type="pmid">15168336</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>T</given-names></name><name><surname>Haskell</surname><given-names>J</given-names></name><name><surname>Vinson</surname><given-names>N</given-names></name><name><surname>Terracio</surname><given-names>L</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>Characterization of insulin and insulin-like growth factor I receptors of purified Leydig cells and their role in steroidogenesis in primary culture: a comparative study</article-title><source>Endocrinology</source><volume>119</volume><fpage>1641</fpage><lpage>1647</lpage><pub-id pub-id-type="doi">10.1210/endo-119-4-1641</pub-id><pub-id pub-id-type="pmid">2944738</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Rodriguez</surname><given-names>K</given-names></name><name><surname>Yao</surname><given-names>HHC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mapping lineage progression of somatic progenitor cells in the mouse fetal testis</article-title><source>Development</source><volume>143</volume><fpage>3700</fpage><lpage>3710</lpage><pub-id pub-id-type="doi">10.1242/dev.135756</pub-id><pub-id pub-id-type="pmid">27621062</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Midzak</surname><given-names>AS</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Papadopoulos</surname><given-names>V</given-names></name><name><surname>Zirkin</surname><given-names>BR</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Leydig cell aging and the mechanisms of reduced testosterone synthesis</article-title><source>Molecular and Cellular Endocrinology</source><volume>299</volume><fpage>23</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.mce.2008.07.016</pub-id><pub-id pub-id-type="pmid">18761053</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ocón-Grove</surname><given-names>OM</given-names></name><name><surname>Krzysik-Walker</surname><given-names>SM</given-names></name><name><surname>Maddineni</surname><given-names>SR</given-names></name><name><surname>Hendricks</surname><given-names>GL</given-names></name><name><surname>Ramachandran</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>NAMPT (visfatin) in the chicken testis: influence of sexual maturation on cellular localization, plasma levels and gene and protein expression</article-title><source>REPRODUCTION</source><volume>139</volume><fpage>217</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1530/REP-08-0377</pub-id><pub-id pub-id-type="pmid">19736255</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potter</surname><given-names>SJ</given-names></name><name><surname>DeFalco</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Role of the testis interstitial compartment in spermatogonial stem cell function</article-title><source>Reproduction</source><volume>153</volume><fpage>R151</fpage><lpage>R162</lpage><pub-id pub-id-type="doi">10.1530/REP-16-0588</pub-id><pub-id pub-id-type="pmid">28115580</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>X</given-names></name><name><surname>Hill</surname><given-names>A</given-names></name><name><surname>Packer</surname><given-names>J</given-names></name><name><surname>Lin</surname><given-names>D</given-names></name><name><surname>Ma</surname><given-names>YA</given-names></name><name><surname>Trapnell</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Single-cell mRNA quantification and differential analysis with Census</article-title><source>Nature Methods</source><volume>14</volume><fpage>309</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4150</pub-id><pub-id pub-id-type="pmid">28114287</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>AJ</given-names></name><name><surname>Skinner</surname><given-names>MK</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Mesenchymal-epithelial cell interactions in the ovary: estrogen-induced theca cell steroidogenesis</article-title><source>Molecular and Cellular Endocrinology</source><volume>72</volume><fpage>R1</fpage><lpage>R5</lpage><pub-id pub-id-type="doi">10.1016/0303-7207(90)90242-z</pub-id><pub-id pub-id-type="pmid">2272402</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>YC</given-names></name><name><surname>Shami</surname><given-names>AN</given-names></name><name><surname>Moritz</surname><given-names>L</given-names></name><name><surname>Larose</surname><given-names>H</given-names></name><name><surname>Manske</surname><given-names>GL</given-names></name><name><surname>Ma</surname><given-names>Q</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Sukhwani</surname><given-names>M</given-names></name><name><surname>Czerwinski</surname><given-names>M</given-names></name><name><surname>Sultan</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Gurczynski</surname><given-names>SJ</given-names></name><name><surname>Spence</surname><given-names>JR</given-names></name><name><surname>Orwig</surname><given-names>KE</given-names></name><name><surname>Tallquist</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>JZ</given-names></name><name><surname>Hammoud</surname><given-names>SS</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>TCF21<sup>+</sup> mesenchymal cells contribute to testis somatic cell development, homeostasis, and regeneration in mice</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>3876</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-24130-8</pub-id><pub-id pub-id-type="pmid">34162856</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shima</surname><given-names>Y</given-names></name><name><surname>Matsuzaki</surname><given-names>S</given-names></name><name><surname>Miyabayashi</surname><given-names>K</given-names></name><name><surname>Otake</surname><given-names>H</given-names></name><name><surname>Baba</surname><given-names>T</given-names></name><name><surname>Kato</surname><given-names>S</given-names></name><name><surname>Huhtaniemi</surname><given-names>I</given-names></name><name><surname>Morohashi</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Fetal leydig cells persist as an androgen-independent subpopulation in the postnatal testis</article-title><source>Molecular Endocrinology</source><volume>29</volume><fpage>1581</fpage><lpage>1593</lpage><pub-id pub-id-type="doi">10.1210/me.2015-1200</pub-id><pub-id pub-id-type="pmid">26402718</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shima</surname><given-names>Y</given-names></name><name><surname>Miyabayashi</surname><given-names>K</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Suyama</surname><given-names>M</given-names></name><name><surname>Ohkawa</surname><given-names>Y</given-names></name><name><surname>Doi</surname><given-names>M</given-names></name><name><surname>Okamura</surname><given-names>H</given-names></name><name><surname>Suzuki</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Fetal Leydig cells dedifferentiate and serve as adult Leydig stem cells</article-title><source>Development</source><volume>145</volume><elocation-id>dev169136</elocation-id><pub-id pub-id-type="doi">10.1242/dev.169136</pub-id><pub-id pub-id-type="pmid">30518625</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuart</surname><given-names>T</given-names></name><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Hoffman</surname><given-names>P</given-names></name><name><surname>Hafemeister</surname><given-names>C</given-names></name><name><surname>Papalexi</surname><given-names>E</given-names></name><name><surname>Mauck</surname><given-names>WM</given-names></name><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Stoeckius</surname><given-names>M</given-names></name><name><surname>Smibert</surname><given-names>P</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Comprehensive integration of single-cell data</article-title><source>Cell</source><volume>177</volume><fpage>1888</fpage><lpage>1902</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.05.031</pub-id><pub-id pub-id-type="pmid">31178118</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Zhong</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>K</given-names></name><name><surname>Hou</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Xie</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Wei</surname><given-names>X</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Yu</surname><given-names>Q</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Volpe</surname><given-names>G</given-names></name><name><surname>Qiu</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Ward</surname><given-names>C</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Yin</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Esteban</surname><given-names>MA</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Dean</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Fan</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma</article-title><source>Cell</source><volume>184</volume><fpage>404</fpage><lpage>421</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.11.041</pub-id><pub-id pub-id-type="pmid">33357445</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trapnell</surname><given-names>C</given-names></name><name><surname>Cacchiarelli</surname><given-names>D</given-names></name><name><surname>Grimsby</surname><given-names>J</given-names></name><name><surname>Pokharel</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Morse</surname><given-names>M</given-names></name><name><surname>Lennon</surname><given-names>NJ</given-names></name><name><surname>Livak</surname><given-names>KJ</given-names></name><name><surname>Mikkelsen</surname><given-names>TS</given-names></name><name><surname>Rinn</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells</article-title><source>Nature Biotechnology</source><volume>32</volume><fpage>381</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1038/nbt.2859</pub-id><pub-id pub-id-type="pmid">24658644</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>Q</given-names></name><name><surname>Cheng</surname><given-names>CY</given-names></name><name><surname>Liu</surname><given-names>YX</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Development, function and fate of fetal Leydig cells</article-title><source>Seminars in Cell &amp; Developmental Biology</source><volume>59</volume><fpage>89</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2016.03.003</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whyte</surname><given-names>WA</given-names></name><name><surname>Orlando</surname><given-names>DA</given-names></name><name><surname>Hnisz</surname><given-names>D</given-names></name><name><surname>Abraham</surname><given-names>BJ</given-names></name><name><surname>Lin</surname><given-names>CY</given-names></name><name><surname>Kagey</surname><given-names>MH</given-names></name><name><surname>Rahl</surname><given-names>PB</given-names></name><name><surname>Lee</surname><given-names>TI</given-names></name><name><surname>Young</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Master transcription factors and mediator establish super-enhancers at key cell identity genes</article-title><source>Cell</source><volume>153</volume><fpage>307</fpage><lpage>319</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.03.035</pub-id><pub-id pub-id-type="pmid">23582322</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>T</given-names></name><name><surname>Hu</surname><given-names>E</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Guo</surname><given-names>P</given-names></name><name><surname>Dai</surname><given-names>Z</given-names></name><name><surname>Feng</surname><given-names>T</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Tang</surname><given-names>W</given-names></name><name><surname>Zhan</surname><given-names>L</given-names></name><name><surname>Fu</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Bo</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>clusterProfiler 4.0: A universal enrichment tool for interpreting omics data</article-title><source>Innovation</source><volume>2</volume><elocation-id>100141</elocation-id><pub-id pub-id-type="doi">10.1016/j.xinn.2021.100141</pub-id><pub-id pub-id-type="pmid">34557778</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>LG</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>QY</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>clusterProfiler: an R package for comparing biological themes among gene clusters</article-title><source>OMICS</source><volume>16</volume><fpage>284</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1089/omi.2011.0118</pub-id><pub-id pub-id-type="pmid">22455463</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zang</surname><given-names>ZJ</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Su</surname><given-names>Z</given-names></name><name><surname>Tuo</surname><given-names>Y</given-names></name><name><surname>Liao</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Yuan</surname><given-names>Q</given-names></name><name><surname>Deng</surname><given-names>C</given-names></name><name><surname>Jiang</surname><given-names>MH</given-names></name><name><surname>Xiang</surname><given-names>AP</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Transplantation of CD51<sup>+</sup> stem leydig cells: a new strategy for the treatment of testosterone deficiency</article-title><source>Stem Cells</source><volume>35</volume><fpage>1222</fpage><lpage>1232</lpage><pub-id pub-id-type="doi">10.1002/stem.2569</pub-id><pub-id pub-id-type="pmid">28090714</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Xia</surname><given-names>S</given-names></name><name><surname>Xiao</surname><given-names>W</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>L</given-names></name><name><surname>Cao</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>A single-cell transcriptomic landscape of mouse testicular aging</article-title><source>Journal of Advanced Research</source><volume>53</volume><fpage>219</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1016/j.jare.2022.12.007</pub-id><pub-id pub-id-type="pmid">36528294</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zirkin</surname><given-names>BR</given-names></name><name><surname>Papadopoulos</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Leydig cells: formation, function, and regulation</article-title><source>Biology of Reproduction</source><volume>99</volume><fpage>101</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1093/biolre/ioy059</pub-id><pub-id pub-id-type="pmid">29566165</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.100396.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Postovit</surname><given-names>Lynne-Marie</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02y72wh86</institution-id><institution>Queen's University</institution></institution-wrap><addr-line><named-content content-type="city">Kingston</named-content></addr-line><country>Canada</country></aff></contrib></contrib-group></front-stub><body><p>This Important study presents the dynamics and diversity of Leydig cells (LC) across the lifespan, in particular the delineation of Cd34-MC1 as a progenitor source for LC maintenance and regeneration. The evidence supporting the claims is solid and this work will be of interest to investigators in the field of male reproduction.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.100396.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Postovit</surname><given-names>Lynne-Marie</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02y72wh86</institution-id><institution>Queen's University</institution></institution-wrap><addr-line><named-content content-type="city">Kingston</named-content></addr-line><country>Canada</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Zhao</surname><given-names>Xiaoyang</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01vjw4z39</institution-id><institution>Department of Developmental Biology, School of Basic Medical Sciences, Southern Medical University</institution></institution-wrap><country>China</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2_6-box1"><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;A comprehensive atlas of testicular interstitium reveals Cd34+/Sox4+ mesenchymal cells as potential Leydig cell progenitors&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Lynne-Marie Postovit as the Senior Editor.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential Revisions:</p><p>1) The paper should be edited for clarity, and spelling as described in the reviewers reports. In particular, the authors should remove irrelevant information and should articulate the novelty of the work.</p><p>2) In terms of data analysis, the author should eliminate batch effects and provide detailed analysis procedures, which are crucial for the reliability of the defined cell subpopulations and the lineage differentiation of LCs. For example, the authors should take care to eliminate contaminating cells in the scRNAseq experiments. Additionally, the presence of negative values for gene expression in most of the figures (e.g., Fig2K) can be addressed by annotating the z-score in the legend or by presenting the readers with normalized gene expression values, as gene expression inherently does not have negative values. The current annotation method in the text is prone to mislead readers.</p><p>3) The authors should refer to the classical evaluation standards of SLC transplantation experiments and use more comprehensive data to support the findings of this paper. Additionally, knockdown experiments should include analysis at the protein level (supplementary Fig6), and further verification is needed to check whether the results from immunostaining are consistent with the statistics (e.g. Fig1H).</p><p>4) The CD34+ population should be better described and more specific markers should be added to distinguish PLC,ILC and MLC.</p><p>5) All antibodies (for example against HSD3B1) should be validated with positive and negative controls to ensure specificity.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>Huang et al., conducted a comprehensive analysis of the sc-transcriptomic landscape of the murine testicular interstitium across the postnatal lifespan. Moreover, they proposed Cd34-MC1 as a potential Leydig cell progenitor. In detail, these cells exhibited self-renewal capacity and potential to differentiate into LC. Notably, upon being transplanted into EDS or Lhcgr-/- models, Cd34-MC1 could colonize the testicular interstitium, generating an increase in testosterone production. They further identified Sox4 in maintaining the stemness of Cd34-MC1. Besides, a decline in glutathione levels within the testicular interstitium was observed during the aging process. Altogether, this work broadens the understanding of a possible progenitor source for LC, which may provide a new tool for the studies of testosterone deficiency treatment.</p><p>However, many conclusions in this study are not well supported by sufficient evidence, and more rigor should be applied to data analysis and experimental design.</p><p>1. There are several issues in data analysis that affect cell definition and specificity of developmental stage, leading to less reliable conclusions regarding LC lifespan: 1) the definition of cell identities lacks supporting evidence from literature, for instance, mesenchymal cell and PLC; 2) the authors have not clarified whether they have excluded doublets from the analysis and whether the AC subpopulation still exists after the removal of doublets? The low number of ACs observed in Fig1G raises this concern; 3) regarding the analysis of LC within the lifespan, the pseudo-time trajectory presented in Figure 2C appears to have batch effects; 4) in Fig2I, aging LCs and the majority of Adult PTMs are distributed at the starting point of differentiation, whereas ILCs are mostly located at the end of differentiation. It is therefore recommended to supplement the pseudo-time plot to clarify the starting point of differentiation more definitively.</p><p>2. The developmental stage and molecular characteristics of Cd34-MC1 are not clear. For instance, Fig2D shows that Cd34-MC1 is predominantly present at 1 week, while Cd34-MC2 and 3 are observed from 1 month to 24 months. However, in Fig2G, the samples are derived from 3-week-old mice, raising the question that which Cd34-MC subpopulation at this stage. Furthermore, what are the molecular differences between the various CD34-MC subpopulations 1, 2, and 3? For the in vitro culture experiments and in vivo transplantation assay, how can authors ensure that the starting cells are indeed Cd34-MC1 rather than other subpopulations? Identifying these differences and establishing robust markers for each subpopulation is crucial for accurate characterization and manipulation of these cells.</p><p>3. The data of in vitro culture experiments and in vivo transplantation assay are incomplete, making it difficult to conclude that these cells are progenitor Leydig cells. For example, the isolation of primary cells lacks verification of purity and statistical analysis (Figure 4A-B). Additionally, transplantation experiments require distinguishing the cell origin from the donor, by which the EDS model fails to demonstrate whether the generated hsd3b1 cells are derived from self-recovery. Although the transplantation of Cd34-MC1 cells from tdTomato+ mice into Lhcgr-/- mice represents a more rigorous model, it also lacks sufficient evidence to show that these cells differentiate into LCs and exert relevant functions appropriately. For instance, there is a lack of comparison between LCs and testosterone levels with those of normal physiological mice, as well as an analysis of HPG axis regulation and assessment of spermatogenesis. Consequently, these results fall short of achieving the goal of improving fertility for patients with hypogonadism, as intended by this study.</p><p>4. Another concern is what novelty does Cd34-MC1 have compared with other Stem/progenitor sources for LC that have been reported, including CD51+, tcf21+, etc.</p><p>5. In terms of writing, the focus of the article is unclear. A large part of the article elaborates on the metabolic changes in the aging process of LCs and the impact of macrophages on LCs, but it seems irrelevant with CD34+/Sox4+ MCs. Moreover, due to the lack of comparison with other stem/progenitor LC in previous reports, the novelty and significance of this work remain elusive.</p><p>6. In terms of data analysis, the author should eliminate batch effects and provide detailed analysis procedures, which are crucial for the reliability of the defined cell subpopulations and the lineage differentiation of LCs. Additionally, the presence of negative values for gene expression in most of the figures (e.g., Fig2K) can be addressed by annotating the z-score in the legend or by presenting the readers with normalized gene expression values, as gene expression inherently does not have negative values. The current annotation method in the text is prone to mislead readers.</p><p>7. It's recommended to refer to the classical evaluation standards of SLC transplantation experiments and use more comprehensive data to support the findings of this paper. Additionally, knockdown experiments should include analysis at the protein level (supplementary Fig6), and further verification is needed to check whether the results from immunostaining are consistent with the statistics (e.g. Fig1H).</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>The testicular interstitial Leydig cells play critical roles in maintaining reproductive functionality. However, there remain significant gaps in understanding how the cells are formed and maintained, as well as how aging might affect the cells and their precursors. The current study addressed these questions in one aspect, using animals from the neonatal stage up to the aged. The authors conducted a comprehensive analysis of the single-cell transcriptomic landscape of the murine testicular interstitium throughout the postnatal lifespan (ages of 1 week, 1 month, 2 months, 8 months, and 24 months), with a focus on Leydig cells and their precursors (CD34+/SOX4+ mesenchymal cells).</p><p>The study identified a new marker for stem Leydig cells (CD34) and the key regulatory molecule (SOX4) which governs the differentiation of CD34+ cells. The identification of SOX4 as a stem cell maintenance factor is significant. The study also identified a new cell type, &quot;ambiguous cell,&quot; that expressed all the key markers of both Leydig cells and macrophages. Regarding the aging of CD34+ mesenchymal cells, glutathione reduction and ROS up-regulation seem to play important roles. Unfortunately, given the ambitious goals and the flaws in data collections and analyses, not all conclusions are solid. Most importantly, the major biological question is not entirely clear. Despite the large amounts of data, the novelty of the study is limited due to the questionable scRNA-seq dataset and an unfocused biological question. scRNA-seq analysis of aging mice testis has been conducted before. The finding of CD34 as a new stem Leydig cell marker is not particularly novel either since about 10 such markers have been reported over the years, including the four from the researcher's own lab. One of the major flaws is the failure to compare the difference and similarity of the new marker with the ones reported previously.</p><p>Strengths:</p><p>a) The study encompassed a large number of experimental groups covering the entire lifespan, from neonatal (age of 1 week) to postnatal (1 month-old), young adult (2 months), middle age (8 months), and aged (24 months).</p><p>b) The study covered Leydig cells, their precursors, and their potential regulatory cells (other interstitial cells).</p><p>c) Diverse tools were employed to address the questions, including scRNA-seq, in vitro CD34+ cell differentiation, in vivo cell transplantation, ChIP-seq, and Sox4 expression interference.</p><p>d) Identification of CD34 as a stem Leydig cell marker.</p><p>e) Identification of SOX4 as a stem Leydig cell maintenance factor.</p><p>Weaknesses:</p><p>a) The study included numerous groups, cells, and a wealth of data. Cells of the entire interstitial compartment were addressed, including Leydig cells, Leydig precursor cells (CD34+ mesenchymal cells), and macrophages. However, the major biological question addressed is not entirely clear. In lines 290-292, the authors declared: &quot;The principal objective … was to elucidate dynamics and diversity of Leydig cells across the lifespan,&quot; but the data were all pointed to Leydig stem cells (CD34+ cells). Also, the diversity of Leydig cells and their precursors identified was not about diversity but about the developing stages of the cells, as they were associated with different ages.</p><p>b) The study established CD34 as a new stem Leydig cell marker. However, the study did not go far enough to establish the relationships between CD34 and the many similar markers reported previously, including those reported by the researcher's own lab. Generally, these markers all label interstitial mesenchymal cells, with some targeting peritubular cells, perivascular cells, or even endothelial cells (Nat Commun, 2021;12(1):3876; Andrology, 2020;8(5):1265). Since many similar markers were identified before, the significance of this new marker is not clear. Important questions remain: Did CD34 identify a particular population that is different from the cells identified by the previous markers? Since the Cd34+ cells were confirmed by the same in vitro differentiation and in vivo transplantation experiments as were done for other markers in previous studies, what is the novelty of the new marker? Could one obtain purer cells by CD34 compared to other markers?</p><p>c) Failure to establish the relationship between CD34+ cells and the newly found telocytes. Testicular CD34+/PDGFRA+ cells were recently established as telocytes. Did the authors do careful morphology studies to determine whether the isolated CD34+ cells exhibit elongated morphology? Did the CD34+ cells isolated by the authors represent the telocyte population or a particular subpopulation serving as stem cells? Did the CD34-M1, -M2, and -M3 represent the precursors and the fully developed and aged telocytes?</p><p>d) The manuscript lacks technical details regarding the scRNA-seq experiment, which raises questions about the data quality. For instance, how the cells were enriched and by what markers were not described in depth. The study mentioned 3 antibodies used in cell enrichment, but how they were utilized was not described. Also, it should be kept in mind that cell enrichment by a particular marker runs a risk of eliminating certain cell types, so the atlas could be incomplete. This also leads to an opposite question: why a significant number of germ cells were present after the enrichment (Figure S1B)?</p><p>e) The most crucial issue that may affect the scRNA-seq data quality is cell cross-contamination. For example, the manuscript failed to provide technique details about the number of cells loaded and captured for each sample and the percentages of &quot;doublets&quot; and &quot;triplets&quot; expected. A higher number of cell loading could lead to significant &quot;doublets&quot; and &quot;triplets&quot;. Did the authors apply any specific tools or steps to eliminate the low-quality cells, especially those involving &quot;doublets&quot; and &quot;triplets&quot;? These details are important since the study identified a new cell type, &quot;ambiguous cell.&quot; Since this new cell type expressed all the important Leydig cell and macrophage markers (Figure 1C, 1F, 2B, S3B, S3E), it most likely represented a group of Leydig cell/macrophage mixture cells (&quot;doublets&quot; and/or &quot;triplets&quot;). The severe contamination of CD45/F4-80 and Lhcgr to the mesenchymal cluster area (Figure S1E) strongly suggests this possibility. Even the markers for tiny T-cell (Cd3e) and B-cell (Cd79a) clusters were noticed in other cluster areas (Figure S3E).</p><p>f) For the presence of &quot;ambiguous cells,&quot; more evidence is required, as such a cell type has never been reported before. In addition to the RNA data, the authors provided an immunofluorescence figure (Figure 1G). However, for immunofluorescence co-staining, it is well-known that one color, if the signal is too strong, could leak into another color. The original immunofluorescence photo with raw resolution could provide more details. It would be even better if the field contained 3 cell types (Leydig, macrophage, and ambiguous cell) simultaneously. Other forms of evidence could also be helpful.</p><p>g) In the Discussion section, the manuscript was deficient in light of previously published literature. In addition to the references on stem LC markers mentioned above, the authors also failed to discuss in depth the major findings of previous scRNA-seq articles involving testicular aging, especially the recent one dealing with aging mice testes (Journal of Advanced Research 2023, 53: 219-234).</p><p>h) In the summary figure (Figure 5J), the authors concluded that CD34+ cells from aged animals lost the capacity to generate Leydig cells. Such a conclusion lacks direct in vivo evidence. The authors presented a compelling story through in vitro experiments that the D34+ MCs of neonatal animals gradually reduced their ability to form Leydig cells as the animals matured and aged. However, the study did not test in vivo whether old animals could lose the ability to form new Leydig cells in the event that the aged Leydig cells were damaged or eliminated.</p><p>1. Provide more technical details and quality-control data, or reanalyze the scRNA-seq data to eliminate potentially contaminated cells. Such steps are necessary to firmly establish the new cell type (ambiguous cell) and to eliminate other inaccurate results of the contaminated clusters.</p><p>2. Figure 1B lacks age information.</p><p>3. Do CD34+ cells also express other previously identified stem cell markers? Do they represent the same or a different population of cells?</p><p>4. Figure 3B, 3C: It is unusual to display data from old to young.</p><p>5. Figure S3A and other places: The marker genes/proteins used for PLC, ILC, and MLC (Hsd3b6, Cyp51, Cyp17a1, Hsd3b1, etc) are not specific enough to distinguish these developmental stages. More specific markers are needed.</p><p>6. Figure 1G: Were the colors of HSD3B1 and F4-80 switched between interstitial and peritubular by mistake or on purpose?</p><p>7. Figure 1H: HSD3B1+ cells appeared inside of seminiferous tubules in 1W and 8-month samples. Are they genuine positive cells or an antibody issue?</p><p>8. Line 46: Change &quot;express&quot; to &quot;produce&quot;.</p><p>[Editors' note: further revisions were suggested prior to acceptance, as described below.]</p><p>Thank you for resubmitting your work entitled &quot;A comprehensive atlas of testicular interstitium reveals Cd34<sup>+</sup>/Sox4<sup>+</sup> mesenchymal cells as potential Leydig cell progenitors&quot; for further consideration by <italic>eLife</italic>. Your revised article has been evaluated by Lynne-Marie Postovit (Senior Editor) and a Reviewing Editor.</p><p>The manuscript has been improved but there are some remaining issues that need to be addressed, as outlined below:</p><p>Given concerns raised by reviewer #2, the authors should further refine the scRNA sequencing data as outlined in the comments. Ideally, they should have more functional data to support their conclusion that they have found a new progenitor population. Alternatively, their conclusions should be muted, highlighting the need for further experimentation.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>The revision addressed the comments mostly with satisfaction. However, a few key issues still persist, which prevent the publication of the data in its present form.</p><p>Key issues:</p><p>1. The refusal to reanalyze the scRNA-seq data is a great disappointment, as both reviewers suggested that the scRNA-seq data required cleanup to remove doublets and batch effects. No significant changes were made to the scRNA-seq results (see the first three figures).</p><p>2. Regarding the lack of a major biological question: The revised manuscript has improved substantially but still falls short in some aspects. According to the response to Q1 from Reviewer 2, the authors stated that the major aim is to &quot;identify and functionally characterize Leydig cell progenitor populations that sustain Leydig cell homeostasis across the lifespan&quot;. First, this is not reflected in the title. Additionally, it seems the authors attempted to address two distinct biological questions simultaneously. One concerns the establishment of Cd34+/Sox4 as a new SLC marker, while the other relates to &quot;the Leydig cell progenitor populations that sustain Leydig cell homeostasis across the lifespan&quot;. The authors presented these two objectives in a way that they interfere with each other.</p><p>To argue that the Cd34+/Sox4 populations are superior to previously published populations in generating LCs, the authors stated, &quot;The extensive functional and mechanistic validations clearly set the Cd34+/Sox4 progenitors apart from previously described populations&quot; and &quot;This section clearly highlights differences in marker expression, developmental dynamics, and functional capacities… of progenitor populations (e.g., Pdgfra++, Arx++, Tcf21++)&quot;. These statements are precisely what troubles this reviewer. If the new Cd34+/Sox4 progenitors are significantly different from previously identified populations, then the studies on the second part (progenitors in developmental stages and aging) only addressed a &quot;part&quot; of generating capacity. How important is this specific Cd34+ population in overall LC regeneration? Could the loss of this specific generating capacity be compensated for by other populations? The authors need to emphasize their similarities rather than their differences.</p><p>3. Establishment of ACs as a new cell type: Although the authors cleaned up the scRNA-seq dataset and provided new immunohistochemistry data to support their conclusion, antibody-based methods can easily produce &quot;false positive&quot; results. Regarding &quot;doublet removal&quot;: while the authors applied computational tools (DoubletFinder) to remove doublets, these bioinformatics tools do not guarantee doublet-free samples. Most of the time, human involvement is required. For example, Supplemental Figure 1E clearly shows that &quot;doublet removal&quot; did not reach an acceptable level. Considering all the data and arguments, this reviewer still believes that the new AC cell is a &quot;false positive observation&quot; based on the following points:</p><p>a) The scRNA-seq data remains questionable regarding the presence of such a cell. The markers shown for ACs in the heatmap in Figure 1D include typical LC markers (Hsd3b1 and Star). How could these typical steroidogenic LC markers be enriched in a non-LC type rather than in LCs themselves? Does this mean these hybrid cells expressed even higher levels of steroidogenic genes than true LCs?</p><p>b) The quality of the scRNA-seq data is still questionable. Note the fragmentation of marker genes across all cell types (Figure 1D), which is not typical in scRNA-seq studies.</p><p>c) Rodent testes have been extensively studied by various researchers over the years, and none have identified this specific cell type, including in multiple recent scRNA-seq studies of mouse testes (developmental, adult, and aging).</p><p>d) The new cell type lacks biological plausibility.</p><p>In summary: The authors need more robust data to establish a new cell type in the testis. To firmly validate such a cell, they must conduct new experiments, including isolating the cells and characterizing their properties in vitro; defining their precursors; and tracing their developmental lineage, among other steps. Until then, this reviewer suggests treating these cells as a &quot;false positive observation&quot; resulting from inaccurate biological datasets. Other possibilities for this confusing cell type include: residual LC fragments in macrophages due to active phagocytosis, or failure to separate LCs and macrophages due to specialized cell membrane contacts between the two cell types.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.100396.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential Revisions:</p><p>Reviewer #1 (Recommendations for the authors):</p><p>Huang et al., conducted a comprehensive analysis of the sc-transcriptomic landscape of the murine testicular interstitium across the postnatal lifespan. Moreover, they proposed Cd34-MC1 as a potential Leydig cell progenitor. In detail, these cells exhibited self-renewal capacity and potential to differentiate into LC. Notably, upon being transplanted into EDS or Lhcgr-/- models, Cd34-MC1 could colonize the testicular interstitium, generating an increase in testosterone production. They further identified Sox4 in maintaining the stemness of Cd34-MC1. Besides, a decline in glutathione levels within the testicular interstitium was observed during the aging process. Altogether, this work broadens the understanding of a possible progenitor source for LC, which may provide a new tool for the studies of testosterone deficiency treatment.</p><p>However, many conclusions in this study are not well supported by sufficient evidence, and more rigor should be applied to data analysis and experimental design.</p><p>1. There are several issues in data analysis that affect cell definition and specificity of developmental stage, leading to less reliable conclusions regarding LC lifespan: 1) the definition of cell identities lacks supporting evidence from literature, for instance, mesenchymal cell and PLC; 2) the authors have not clarified whether they have excluded doublets from the analysis and whether the AC subpopulation still exists after the removal of doublets? The low number of ACs observed in Fig1G raises this concern; 3) regarding the analysis of LC within the lifespan, the pseudo-time trajectory presented in Figure 2C appears to have batch effects; 4) in Fig2I, aging LCs and the majority of Adult PTMs are distributed at the starting point of differentiation, whereas ILCs are mostly located at the end of differentiation. It is therefore recommended to supplement the pseudo-time plot to clarify the starting point of differentiation more definitively.</p></disp-quote><p>Thank you for your constructive comments regarding the cell identity definitions and developmental stage specificity in our analysis. In response, we have made several revisions and additional analyses to address your concerns:</p><p>1) In the revised manuscript, we have clearly defined mesenchymal cells (MCs) as testicular stromal cells, aligning with classic descriptions by Skinner (1990) and Kfoury &amp; Scadden (2015), and further reinforced by citing recent studies that specifically characterize mesenchymal progenitors within the testis (Abe, 2022). Moreover, progenitor Leydig cells (PLCs) are explicitly defined as Leydig progenitors, consistent with well-established lineage characterizations described by Mendis-Handagama &amp; Ariyaratne (2009) and supported by recent literature (Shen et al., 2021; Chikhovskaya et al., 2014; Jiang et al., 2014). Leydig cells (LCs) are classified based on their developmental stages, following the authoritative review by Chen et al. (2009) (see revised manuscript line 517-527).</p><p>To further substantiate these definitions experimentally, we have now included:</p><p>(i) A dot plot (New Figure 1A, related to Figure 2B) illustrating differential gene expression patterns across CD34⁺ MC, PLC, immature Leydig cells (ILC), and mature Leydig cells (MLC).</p><p>(ii) Gene Ontology (GO) analysis (New Figure 1B, related to Figure supplement 2C) highlighting enriched biological functions associated with characteristic marker genes in each subpopulation.</p><p>References: Skinner MK, Reprod Fertil Dev, 1990; Kfoury Y &amp; Scadden DT, Cell Stem Cell, 2015; Abe, Int J Mol Sci, 2022; Chikhovskaya JV et al., Mol Hum Reprod, 2014; Shen YC et al., Nat Commun, 2021; Jiang MH et al., Cell Res, 2014; Mendis-Handagama SM &amp; Siril Ariyaratne HB; Chen H et al., Mol Cell Endocrinol, 2009.</p><p>2) We appreciate the reviewer’s important concern about potential doublet contamination. To address this explicitly, we implemented stringent doublet detection and removal procedures using the DoubletFinder package in R, ensuring rigorous exclusion of cell barcodes flagged as potential doublets from all downstream analyses (New Figure 2A). Importantly, we found that the removal of doublets did not substantially alter overall cell distribution patterns (New Figure 2B).</p><p>Moreover, the ambiguous cell (AC) subpopulation was consistently identified after doublet exclusion (New Figure 2B), confirming its robustness as a genuine biological subpopulation rather than a technical artifact. Furthermore, independent validation through immunofluorescence staining clearly demonstrates the presence and localization of ACs, macrophages, and interstitial cells within the testicular interstitium (New Figure 2C, related to revised Figure 1G).</p><p>3) We appreciate the reviewer’s thoughtful comment regarding potential batch effects in the pseudotime trajectory analysis. To rigorously address this concern, we have now applied two independent batch correction methods, Seurat’s integration approach and the Harmony algorithm, to the single-cell RNA sequencing dataset. Importantly, both batch correction methods yielded highly consistent cell groupings, clustering patterns, and pseudotime trajectories (New Figure 2B; New Figure 3A, B). The robust consistency between these independent analyses strongly supports that the developmental transitions observed in Leydig cells (New Figure 3C, D, related to revised Figure supplement 3A) represent genuine biological phenomena rather than technical artifacts due to batch effects.</p><p>4) We thank the reviewer for pointing out this important observation. The pseudotime trajectory initially shown in Figure 2I was automatically inferred using Monocle's algorithm, which relies solely on transcriptional similarities and progression patterns. However, we agree that explicitly defining the biological differentiation starting point enhances interpretability. Therefore, we have now re-anchored the trajectory root to align with established Leydig cell differentiation pathways. This adjustment appropriately positions CD34-MC and FLC at the beginning of the pseudotime axis, with adult Leydig cells (ALC) located at terminal differentiation stages, thus accurately reflecting their known developmental relationships (New Figure 4, related to revised Figure 2I and Figure supplement 4G, H).</p><disp-quote content-type="editor-comment"><p>2. The developmental stage and molecular characteristics of Cd34-MC1 are not clear. For instance, Fig2D shows that Cd34-MC1 is predominantly present at 1 week, while Cd34-MC2 and 3 are observed from 1 month to 24 months. However, in Fig2G, the samples are derived from 3-week-old mice, raising the question that which Cd34-MC subpopulation at this stage. Furthermore, what are the molecular differences between the various CD34-MC subpopulations 1, 2, and 3? For the in vitro culture experiments and in vivo transplantation assay, how can authors ensure that the starting cells are indeed Cd34-MC1 rather than other subpopulations? Identifying these differences and establishing robust markers for each subpopulation is crucial for accurate characterization and manipulation of these cells.</p></disp-quote><p>Thank you for your insightful query regarding the developmental stages and molecular characterization of the Cd34-MC subpopulations. In response, we have made the following revisions and additional analyses:</p><p>1) We appreciate the reviewer’s important point regarding the developmental stage and molecular identity of the Cd34-MC1 subpopulation. We now explicitly define Cd34-MC1 as an early postnatal mesenchymal progenitor subpopulation characterized by progenitor markers (<italic>Cd34</italic>, <italic>Sox4</italic>, <italic>Tcf21</italic>, <italic>Pdgfra</italic>) and enriched stemness-associated pathways. Cd34-MC1 predominates during the neonatal period (~1 week), contributing crucially to the establishment of the expanding Leydig cell population and stromal niche in the young testis. In contrast, Cd34-MC2 emerges at puberty (~1 month) and persists into adulthood, characterized by a decline in early progenitor marker expression (e.g., reduced Sox4) and increased expression of markers involved in cellular support and communication (integrins, VCAM1). Cd34-MC3 arises in aging testes, exhibiting diminished progenitor characteristics and increased expression of inflammatory and fibrotic markers (e.g., Spp1), indicative of reduced regenerative potential.</p><p>Regarding the samples derived from 3-week-old mice (Figure 2G), this age represents a transitional stage wherein the testicular interstitium comprises a mixture of both CD34-MC1 and CD34-MC2 cells. Due to the limited cell number and extremely small size of 1-week-old testicular samples, it was technically challenging to obtain sufficient quantities of CD34-MC1 cells for transplantation experiments. Consequently, samples from slightly older mice (3-week-old) were used, which, although allowing sufficient cell numbers, inevitably introduced a transitional population and slightly reduced cellular purity. We have explicitly clarified this transitional state and experimental rationale in the revised manuscript text (lines 152-157) to directly address the reviewer’s concerns about developmental timing and cell identity.</p><p>2) We thank the reviewer for raising this important point. To clarify the molecular differences among the CD34-MC subpopulations, we have performed additional analyses illustrating distinct gene expression signatures and their corresponding enriched biological pathways. Specifically, previously reported SLC markers are expressed within CD34-MC, predominantly characterizing developmental stages (New Figure 5A-C, related to Figure supplement 4A-C). In contrast, newly identified markers such as Sox4 show specific expression restricted to the juvenile CD34-MC1 subpopulation (New Figure 5D, related to Figure supplement 4D). GO enrichment analysis further revealed clear functional distinctions among the subpopulations: juvenile CD34-MC1 is associated primarily with developmental and regenerative processes; adult CD34-MC2 predominantly relates to tissue remodeling and collagen metabolism; and aged CD34-MC3 is mainly linked to oxidative stress and glutathione metabolism pathways (New Figure 5E, related to revised Figure 2E). We believe these additional data clearly highlight the distinct molecular identities and functional roles of each CD34-MC subpopulation.</p><p>3) We thank the reviewer for raising this critical consideration. To rigorously ensure the identity of the Cd34-MC1 subpopulation in our functional assays, we implemented a combined strategy encompassing developmental timing, marker-based sorting, and subsequent validation. Specifically, cells used in our experiments were isolated from testes during an early postnatal developmental window (1-3 weeks), a stage at which our single-cell RNA sequencing clearly demonstrated predominant enrichment of the Cd34-MC1 subpopulation, while Cd34-MC2 and MC3 populations were either minimally present or not yet fully emerged.</p><p>We acknowledge the technical limitation that fluorescence-activated cell sorting (FACS) using CD34 alone yields a mixed population, comprising approximately 50% Cd34-MC1 cells (Sox4<sup>+</sup>) in 3 weeks testis (New Figure 6A, B, related to revised Supplementary Figure 6L). We have discussed the technical limitation in revised Discussion section (see revised manuscript line 324-326). Nevertheless, we comprehensively addressed this limitation through multiple experimental approaches:</p><p>(i) Importantly, the clonogenic assays in vitro and robust regenerative capacity observed in our transplantation experiments in vivo are specifically linked to progenitor properties. Such properties are specifically attributable to Cd34-MC1 cells rather than Cd34-MC2 or MC3 subsets, which lack substantial regenerative capacity or pronounced stem-like features based on our transcriptional and functional analyses.</p><p>(ii) Additional control experiments performed with aged Cd34-MC3 cells exhibited negligible regenerative potential, clearly contrasting with the potent regenerative capability of early postnatally isolated Cd34-MC1 cells. This functional comparison further confirms that the regenerative outcomes observed specifically reflect the intrinsic progenitor characteristics of the Cd34-MC1 subpopulation (New Figure 6C, D, related to revised Figure 4H, I).</p><p>We have clearly emphasized these points in the revised manuscript to reassure readers and reviewers that, despite limitations in sorting purity, our functional data convincingly represent the intrinsic properties of the Cd34-MC1 progenitor subpopulation.</p><disp-quote content-type="editor-comment"><p>3. The data of in vitro culture experiments and in vivo transplantation assay are incomplete, making it difficult to conclude that these cells are progenitor Leydig cells. For example, the isolation of primary cells lacks verification of purity and statistical analysis (Figure 4A-B). Additionally, transplantation experiments require distinguishing the cell origin from the donor, by which the EDS model fails to demonstrate whether the generated hsd3b1 cells are derived from self-recovery. Although the transplantation of Cd34-MC1 cells from tdTomato+ mice into Lhcgr-/- mice represents a more rigorous model, it also lacks sufficient evidence to show that these cells differentiate into LCs and exert relevant functions appropriately. For instance, there is a lack of comparison between LCs and testosterone levels with those of normal physiological mice, as well as an analysis of HPG axis regulation and assessment of spermatogenesis. Consequently, these results fall short of achieving the goal of improving fertility for patients with hypogonadism, as intended by this study.</p></disp-quote><p>Thank you for your detailed and constructive feedback regarding our in vitro culture and in vivo transplantation experiments. We fully agree that a rigorous demonstration of the identity, functionality, and regenerative potential of these cells as progenitor Leydig cells is essential. In response, we have performed additional experiments and analyses to address your concerns:</p><p>1) To rigorously verify the purity and identity of the isolated CD34⁺ MC1 cells, we have now conducted additional immunostaining experiments after cell sorting, specifically utilizing Sox4, a definitive marker for the MC1 progenitor subpopulation. These analyses confirm that approximately 50% of sorted CD34⁺ cells robustly express Sox4, clearly demonstrating significant enrichment of the MC1 progenitor population used in our assays (New Figure 6A, B, related to revised Supplementary Figure 6L). Although inherent limitations in sorting purity exist, our functional data reliably capture the intrinsic progenitor characteristics of the CD34-MC1 subpopulation (New Figure 6C, D, related to revised Figure 4H, I).</p><p>2) We appreciate the reviewer’s critical assessment regarding the evaluation of transplantation outcomes, particularly concerning cell origin, functional differentiation into Leydig cells, and impacts on fertility-related endpoints such as the hypothalamic-pituitary-gonadal (HPG) axis and spermatogenesis. To directly address these important concerns, we have now provided additional experimental evidence to rigorously demonstrate that transplanted Cd34-MC1 cells from tdTomato⁺ donor mice differentiate into functional Leydig cells within the testes of <italic>Lhcgr</italic><sup>⁻/⁻</sup> recipient mice. Comparative analyses of serum testosterone levels between transplanted <italic>Lhcgr</italic><sup>⁻/⁻</sup> mice and normal physiological controls treated with human chorionic gonadotropin (hCG). This comparison demonstrates substantial restoration of testosterone production, indicative of functional Leydig cell activity following transplantation (New Figure 7, related to revised Figure 4J).</p><p>3) We acknowledge the reviewer’s important point regarding the translational limitations of our current findings. We have carefully revised our manuscript to clearly tone down our claims related to immediate fertility improvement. Instead, we emphasize that our data primarily provide foundational insights into a newly identified Leydig progenitor subpopulation (Cd34⁺/Sox4⁺ mesenchymal cells) with significant regenerative potential and highlight age-related declines in these progenitor cells. We explicitly discuss that further studies will be necessary to establish direct translational implications for fertility restoration in hypogonadal patients.</p><disp-quote content-type="editor-comment"><p>4. Another concern is what novelty does Cd34-MC1 have compared with other Stem/progenitor sources for LC that have been reported, including CD51+, tcf21+, etc.</p></disp-quote><p>We appreciate the reviewer’s concern regarding the novelty of the Cd34-MC1 progenitor population compared to previously reported Leydig cell progenitors (e.g., CD51⁺, Tcf21⁺). While prior studies have characterized CD51⁺ and Tcf21⁺ populations, our identified Cd34⁺/Sox4⁺ mesenchymal progenitors (Cd34-MC1) represent a distinct and previously unrecognized Leydig progenitor subset with several unique molecular and functional attributes:</p><p>1) Distinct Molecular Signature: Cd34-MC1 cells uniquely express a combined marker profile (Cd34⁺/Sox4⁺) identified via unbiased single-cell RNA sequencing, defining a clear molecular identity not previously reported for CD51⁺ or Tcf21⁺ cells. Unlike CD51⁺ progenitors (integrin-defined mesenchymal subset lacking a single definitive transcriptional regulator), Cd34-MC1 cells have a distinct transcription factor, Sox4, essential for maintaining their progenitor state. Compared with Tcf21⁺ progenitors, which are multipotent cells expressing fibroblast-related markers (Pdgfra, Thy1), Cd34-MC1 cells exhibit a more focused stemness and antioxidant gene profile (e.g., Nrf2-driven glutathione metabolism), highlighting their specialized role in Leydig cell regeneration.</p><p>2) Functional Advantages: Cd34-MC1 progenitors have a robust and specific differentiation potential toward Leydig cells, clearly demonstrated by clonogenic colony formation assays and efficient differentiation into functional Leydig cells in vitro and in vivo. This focused differentiation contrasts with the broader mesenchymal multipotency reported for CD51⁺ progenitors and the bipotential differentiation (Leydig/myoid lineages) of Tcf21⁺ progenitors. Importantly, in transplantation experiments, Cd34-MC1 cells showed superior regenerative efficiency, significantly restoring Leydig cell numbers and testosterone levels in adult LC-depleted testes, emphasizing their strong therapeutic potential.</p><p>3) Therapeutic Relevance: Cd34-MC1 progenitors have clear translational promise due to their demonstrated regenerative efficacy in vivo (testosterone recovery, improved spermatogenesis), coupled with the identification of a corresponding human Cd34⁺ mesenchymal progenitor subset. Thus, they represent a potentially advantageous therapeutic target compared with previously reported progenitor populations, which have shown either partial regenerative efficacy (CD51⁺) or are challenging to isolate due to internal marker reliance (Tcf21⁺).</p><p>In summary, Cd34-MC1 cells provide unique insights into Leydig progenitor biology, significantly expanding current knowledge and offering a compelling candidate for future therapeutic strategies targeting Leydig cell failure and hypogonadism.</p><p>We have revised the Discussion section accordingly (see revised manuscript line 308-326).</p><disp-quote content-type="editor-comment"><p>5. In terms of writing, the focus of the article is unclear. A large part of the article elaborates on the metabolic changes in the aging process of LCs and the impact of macrophages on LCs, but it seems irrelevant with CD34+/Sox4+ MCs. Moreover, due to the lack of comparison with other stem/progenitor LC in previous reports, the novelty and significance of this work remain elusive.</p></disp-quote><p>Thank you for your insightful feedback on our manuscript. We have carefully revised the manuscript to sharpen the focus on the Cd34⁺/Sox4⁺ mesenchymal cells (Cd34-MC1) as a novel Leydig progenitor population. Specifically, we addressed your concerns as follows:</p><p>1) We significantly revised the Introduction (lines 69-72) and Discussion (lines 282-292) sections to clearly define the Cd34⁺/Sox4⁺ MC1 cells as the central discovery of our study. The revised text explicitly states the gap in knowledge regarding adult Leydig cell progenitors and highlights the novelty and significance of Cd34⁺/Sox4⁺ MC1 cells in Leydig cell regeneration.</p><p>2) We have reduced detailed discussions of metabolic alterations and macrophage interactions. Specifically, we removed extensive descriptions of oxidative stress and antioxidant defenses from the Introduction. Additionally, content in the Discussion related to metabolism has been removed, and the section discussing macrophages has been substantially condensed and explicitly reframed to serve as supportive context rather than as a primary focus (lines 327-335). These adjustments reinforce the manuscript’s primary focus on the newly identified progenitor population.</p><p>3) To emphasize the novelty clearly, we added a dedicated paragraph in the Discussion section (lines 308-326), explicitly comparing Cd34⁺/Sox4⁺ MC1 progenitors with previously characterized Leydig cell progenitor populations, including Nestin⁺, CD51⁺, and Tcf21⁺ cells. We cited relevant studies (Zhang et al., 2017 for CD51⁺ and Shen et al., 2021 for Tcf21⁺), clearly outlining the distinct molecular signatures (e.g., high Sox4 expression) and robust functional advantages of the Cd34⁺/Sox4⁺ MC1 progenitors.</p><p>4) We revised the overall text structure to improve clarity, ensuring a logical progression from the Introduction’s framing of Leydig cell regeneration problems, through our discovery of Cd34⁺/Sox4⁺ MC1 cells, to clear articulation of their biological and therapeutic significance in the Discussion.</p><disp-quote content-type="editor-comment"><p>6. In terms of data analysis, the author should eliminate batch effects and provide detailed analysis procedures, which are crucial for the reliability of the defined cell subpopulations and the lineage differentiation of LCs. Additionally, the presence of negative values for gene expression in most of the figures (e.g., Fig2K) can be addressed by annotating the z-score in the legend or by presenting the readers with normalized gene expression values, as gene expression inherently does not have negative values. The current annotation method in the text is prone to mislead readers.</p></disp-quote><p>We greatly appreciate the reviewer’s important comments regarding the reliability of our data analysis and clarity of figure annotations.</p><p>1) To rigorously ensure the reliability of defined cell subpopulations and Leydig cell lineage differentiation analysis, we explicitly performed batch correction using two independent and well-validated methods (Harmony and Seurat’s integration). Importantly, these two approaches yielded highly consistent clustering patterns, cellular identities, and differentiation trajectories, confirming that our observations are robust and not influenced by batch artifacts. We have now provided more detailed explanations of these analyses and methodological steps clearly in the revised manuscript (see Methods section line 511-516 and New Figure 3A, B).</p><p>2) We appreciate the reviewer’s important point about the potential for confusion regarding negative gene expression values in our figures. These negative values represent relative gene expression levels calculated through z-score normalization and log-transformation, indicating expression below the mean expression across all cells, not negative absolute expression. To avoid potential confusion, we have clearly annotated this normalization method (z-score normalized, log-transformed relative expression) explicitly in the relevant figure legends of the revised manuscript (line 705-707), ensuring readers interpret the data accurately and transparently.</p><disp-quote content-type="editor-comment"><p>7. It's recommended to refer to the classical evaluation standards of SLC transplantation experiments and use more comprehensive data to support the findings of this paper. Additionally, knockdown experiments should include analysis at the protein level (supplementary Fig6), and further verification is needed to check whether the results from immunostaining are consistent with the statistics (e.g. Fig1H).</p></disp-quote><p>We greatly appreciate the reviewer’s valuable suggestions to enhance the rigor of our functional validations. To address these points explicitly, we have strengthened the revised manuscript as follows:</p><p>1) To clearly align with the classical evaluation standards, we have refined our transplantation model by transplanting tdTomato⁺ donor cells into <italic>Lhcgr</italic><sup>⁻/⁻</sup> mice and performing comprehensive evaluations. Specifically, we quantified Leydig cell numbers and rigorously assessed functional integration through serum testosterone measurements compared to hCG-stimulated controls. These updated analyses (New Figure 7, related to revised Figure 4J) demonstrate significant restoration of Leydig cell numbers and testosterone production, confirming robust and functional integration of transplanted cells into the Leydig cell niche.</p><p>2) As suggested, we have added immunostaining to validate SOX4 knockdown at the protein level, complementing our mRNA-based knockdown results (New Figure 8, related to revised Figure 5F). These protein-level validations confirm effective knockdown at the protein level, aligning closely with our transcript-level data and reinforcing our conclusions.</p><p>3) We appreciate the reviewer’s important point regarding the consistency between immunostaining images and quantitative data (see revised Figure 1H). To explicitly address this concern, we have clarified in the revised manuscript that all presented immunofluorescence images are representative of multiple independent biological replicates. Importantly, our quantitative cell-count analyses from multiple independent fields closely match and robustly support the proportions and staining patterns illustrated in these images, confirming consistency and reproducibility between visual and statistical results.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>The testicular interstitial Leydig cells play critical roles in maintaining reproductive functionality. However, there remain significant gaps in understanding how the cells are formed and maintained, as well as how aging might affect the cells and their precursors. The current study addressed these questions in one aspect, using animals from the neonatal stage up to the aged. The authors conducted a comprehensive analysis of the single-cell transcriptomic landscape of the murine testicular interstitium throughout the postnatal lifespan (ages of 1 week, 1 month, 2 months, 8 months, and 24 months), with a focus on Leydig cells and their precursors (CD34+/SOX4+ mesenchymal cells).</p><p>The study identified a new marker for stem Leydig cells (CD34) and the key regulatory molecule (SOX4) which governs the differentiation of CD34+ cells. The identification of SOX4 as a stem cell maintenance factor is significant. The study also identified a new cell type, &quot;ambiguous cell,&quot; that expressed all the key markers of both Leydig cells and macrophages. Regarding the aging of CD34+ mesenchymal cells, glutathione reduction and ROS up-regulation seem to play important roles. Unfortunately, given the ambitious goals and the flaws in data collections and analyses, not all conclusions are solid. Most importantly, the major biological question is not entirely clear. Despite the large amounts of data, the novelty of the study is limited due to the questionable scRNA-seq dataset and an unfocused biological question. scRNA-seq analysis of aging mice testis has been conducted before. The finding of CD34 as a new stem Leydig cell marker is not particularly novel either since about 10 such markers have been reported over the years, including the four from the researcher's own lab. One of the major flaws is the failure to compare the difference and similarity of the new marker with the ones reported previously.</p></disp-quote><p>We appreciate Reviewer 2’s constructive comments, which helped us improve the clarity and impact of our study. Below we respond point by point to your concerns:</p><p>1) We have clearly stated the primary biological question in the revised manuscript-specifically, our study aims to identify and functionally characterize Leydig cell progenitor populations that sustain Leydig cell homeostasis across the lifespan and to understand how their decline contributes to age-related testosterone deficiency. Using single-cell transcriptomics combined with functional validation, we uniquely identify Cd34<sup>+</sup>/Sox4<sup>+</sup> mesenchymal cells as novel and critical Leydig progenitors whose regenerative potential significantly decreases with aging. These revisions are explicitly reflected in the revised Introduction (lines 69-72) and Discussion (lines 282-292), providing greater clarity and emphasizing the significance and novelty of our findings.</p><p>2) We acknowledge prior scRNA-seq studies on aging testes; however, our study is uniquely focused on identifying and functionally characterizing novel Leydig progenitor populations. Previous studies typically included fewer developmental stages, lacked rigorous functional validation, or did not clearly identify specific progenitor subsets responsible for Leydig cell regeneration. In contrast, our comprehensive developmental timeline (from neonatal to aged mice), coupled with extensive functional validations (clonogenic assays, transplantation experiments, epigenetic profiling), allowed us to uncover the previously unrecognized Cd34⁺/Sox4⁺ mesenchymal cell (MC1) population as a critical and age-sensitive Leydig progenitor subset. Therefore, our data provide novel insights into Leydig cell biology and regenerative mechanisms during aging, substantially extending beyond previously reported analyses.</p><p>3) We acknowledge previous identification of multiple Leydig progenitor markers, including several from our own lab. However, the Cd34<sup>+</sup>/Sox4<sup>+</sup> mesenchymal progenitor population we identify here is distinct and functionally unique compared to previously described Leydig progenitors. Specifically, our study uniquely demonstrates that these Cd34<sup>+</sup>/Sox4<sup>+</sup> progenitors:</p><p>(i) Exhibit robust clonogenic self-renewal capacity, a key hallmark of stemness not comprehensively shown for other markers (see revised Figure 4).</p><p>(ii) Effectively differentiate into mature, testosterone-producing Leydig cells, validated rigorously through in vitro and in vivo transplantation (see revised Figure 4).</p><p>(iii) Are critically regulated by the transcription factor Sox4, whose role in Leydig progenitor maintenance and differentiation we functionally validated (see revised Figure 5).</p><p>Collectively, these extensive functional and mechanistic validations clearly set the Cd34<sup>+</sup>/Sox4<sup>+</sup> progenitors apart from previously described populations, significantly advancing our understanding of Leydig cell regeneration and biology.</p><p>We appreciate the reviewer’s important suggestion. In response, we have added a dedicated section in the revised Discussion explicitly comparing our newly identified Cd34<sup>+</sup>/Sox4<sup>+</sup> mesenchymal progenitors with previously reported Leydig progenitor populations (e.g., Pdgfra<sup>+</sup>, Arx<sup>+</sup>, Tcf21<sup>+</sup>). This section clearly highlights differences in marker expression, developmental dynamics, and functional capacities, such as self-renewal and Leydig cell differentiation. Our comparison demonstrates the unique identity and superior regenerative potential of Cd34<sup>+</sup>/Sox4<sup>+</sup> mesenchymal progenitors (see revised manuscript lines 308-326).</p><disp-quote content-type="editor-comment"><p>Strengths:</p><p>a) The study encompassed a large number of experimental groups covering the entire lifespan, from neonatal (age of 1 week) to postnatal (1 month-old), young adult (2 months), middle age (8 months), and aged (24 months).</p><p>b) The study covered Leydig cells, their precursors, and their potential regulatory cells (other interstitial cells).</p><p>c) Diverse tools were employed to address the questions, including scRNA-seq, in vitro CD34+ cell differentiation, in vivo cell transplantation, ChIP-seq, and Sox4 expression interference.</p><p>d) Identification of CD34 as a stem Leydig cell marker.</p><p>e) Identification of SOX4 as a stem Leydig cell maintenance factor.</p></disp-quote><p>We sincerely appreciate your insightful evaluation and recognition of the strengths of our study.</p><disp-quote content-type="editor-comment"><p>Weaknesses:</p><p>a) The study included numerous groups, cells, and a wealth of data. Cells of the entire interstitial compartment were addressed, including Leydig cells, Leydig precursor cells (CD34+ mesenchymal cells), and macrophages. However, the major biological question addressed is not entirely clear. In lines 290-292, the authors declared: &quot;The principal objective … was to elucidate dynamics and diversity of Leydig cells across the lifespan,&quot; but the data were all pointed to Leydig stem cells (CD34+ cells). Also, the diversity of Leydig cells and their precursors identified was not about diversity but about the developing stages of the cells, as they were associated with different ages.</p></disp-quote><p>Thank you for your constructive feedback regarding the clarity of the biological questions addressed in our study. In response, we have revised our manuscript to explicitly define and support our primary objectives:</p><p>1) Our main aim is to elucidate how the Leydig cell population is maintained and replenished across the lifespan, specifically focusing on the role of Leydig progenitor cells (Cd34⁺ mesenchymal cells). While our initial wording (“dynamics and diversity of Leydig cells”) may have suggested a broader scope, the central biological question indeed revolves around understanding progenitor-driven Leydig cell maintenance, differentiation, and age-related decline. We have clearly stated this revised objective in the manuscript (lines 282-285).</p><p>2) We appreciate your insightful comment regarding the use of the term “diversity.” We have clarified that the Leydig cell subpopulations identified in our study primarily reflect developmental and maturation stages rather than distinct cell lineages. Specifically, our single-cell analyses distinguish immature, mature, and proliferating Leydig cells, each corresponding to specific maturation states linked directly to age and developmental progression. We have revised the manuscript to explicitly communicate this point clearly (lines 69-70, 282-285, 363-365; revised Figure 2A-C)</p><disp-quote content-type="editor-comment"><p>b) The study established CD34 as a new stem Leydig cell marker. However, the study did not go far enough to establish the relationships between CD34 and the many similar markers reported previously, including those reported by the researcher's own lab. Generally, these markers all label interstitial mesenchymal cells, with some targeting peritubular cells, perivascular cells, or even endothelial cells (Nat Commun, 2021;12(1):3876; Andrology, 2020;8(5):1265). Since many similar markers were identified before, the significance of this new marker is not clear. Important questions remain: Did CD34 identify a particular population that is different from the cells identified by the previous markers? Since the Cd34+ cells were confirmed by the same in vitro differentiation and in vivo transplantation experiments as were done for other markers in previous studies, what is the novelty of the new marker? Could one obtain purer cells by CD34 compared to other markers?</p></disp-quote><p>We sincerely appreciate your insightful comments regarding the novelty and significance of CD34 as a Leydig progenitor marker. We agree that clarifying how CD34 relates to previously identified markers is essential. We have carefully addressed your questions as follows:</p><p>1) Previous studies, including our lab's earlier reports and others (Nat Commun, 2021; Andrology, 2020), identified Leydig progenitor markers such as TCF21, PDGFRa, Nestin, and CD51, which labeled broad interstitial populations, including peritubular, perivascular, and occasionally endothelial subsets. In contrast, CD34 distinctly identifies a more restricted subpopulation of interstitial mesenchymal cells. These CD34⁺ cells have a unique telocyte-like morphology and are precisely located at the perivascular-peritubular niche. Importantly, unlike other markers, CD34 expression is largely absent from mature Leydig cells, peritubular myoid cells, and endothelial cells, providing clearer specificity in identifying true Leydig progenitor populations (see revised manuscript line 308-326).</p><p>2) The novelty of CD34⁺ mesenchymal cells goes beyond simply serving as another marker for Leydig progenitors. Specifically, CD34⁺ cells:</p><p>(i) Exhibit robust clonogenic self-renewal capacity in vitro.</p><p>(ii) Efficiently differentiate into mature, testosterone-producing Leydig cells in vitro and after transplantation in vivo.</p><p>(iii) Are uniquely regulated by the transcription factor SOX4, a key regulator of progenitor cell identity not previously identified in other Leydig progenitor subsets.</p><p>(iv) Show significantly superior regenerative potential when transplanted into Leydig-cell-depleted testes.</p><p>These molecular and functional attributes clearly set CD34⁺ progenitors apart from previously reported Leydig progenitor populations, highlighting their distinct biological importance and translational potential.</p><p>3) We thank the reviewer for this important question. Although sorting based solely on CD34 yields ~50% purity of Cd34-MC1 progenitors (as discussed explicitly in our revised Discussion, lines 324-326), CD34 remains advantageous as a surface marker that enables efficient, reproducible isolation. Importantly, our functional validation (clonogenic assays and transplantation experiments) clearly demonstrates that CD34 specifically enriches for progenitors with robust Leydig regenerative potential, distinguishing these cells functionally from other previously reported marker-defined populations.</p><disp-quote content-type="editor-comment"><p>c) Failure to establish the relationship between CD34+ cells and the newly found telocytes. Testicular CD34+/PDGFRA+ cells were recently established as telocytes. Did the authors do careful morphology studies to determine whether the isolated CD34+ cells exhibit elongated morphology? Did the CD34+ cells isolated by the authors represent the telocyte population or a particular subpopulation serving as stem cells? Did the CD34-M1, -M2, and -M3 represent the precursors and the fully developed and aged telocytes?</p></disp-quote><p>We appreciate the reviewer’s insightful comment regarding the relationship between our identified CD34⁺ mesenchymal progenitors and previously reported testicular telocytes. To address your concerns explicitly:</p><p>1) Our CD34⁺ interstitial mesenchymal cells closely correspond to the CD34⁺/PDGFRα⁺ testicular telocytes previously described by Abe et al. (2022), sharing expression of key telocyte markers (Pdgfra, Vcam1) and anatomical locations. However, we identify a previously unrecognized subpopulation within these telocytes, specifically characterized by high expression of Sox4 (CD34⁺/Sox4⁺ cells), and demonstrate unique stem/progenitor properties, including robust clonogenicity and Leydig differentiation potential not previously attributed to telocytes.</p><p>2) Immunofluorescence staining confirmed that isolated CD34⁺ cells display characteristic telocyte morphology, including elongated, spindle-shaped cells with long cytoplasmic processes (&quot;telopodes&quot;) surrounding seminiferous tubules and vessels, consistent with established telocyte architecture (see revised Figure 1H and Figure 2G).</p><p>3) We appreciate the reviewer’s insightful question. To better clarify the molecular differences among the Cd34-MC subpopulations, we have included new analyses (New Figure 5A-D) illustrating distinct gene expression signatures and associated enriched biological pathways (New Figure 5E, related to revised Figure 2E). These molecular analyses clearly demonstrate the progressive transition of Cd34⁺ mesenchymal cells from a regenerative progenitor state (MC1), through a supportive and homeostatic role during adulthood (MC2), to a dysfunctional and inflammatory phenotype associated with aging (MC3).</p><disp-quote content-type="editor-comment"><p>d) The manuscript lacks technical details regarding the scRNA-seq experiment, which raises questions about the data quality. For instance, how the cells were enriched and by what markers were not described in depth. The study mentioned 3 antibodies used in cell enrichment, but how they were utilized was not described. Also, it should be kept in mind that cell enrichment by a particular marker runs a risk of eliminating certain cell types, so the atlas could be incomplete. This also leads to an opposite question: why a significant number of germ cells were present after the enrichment (Figure S1B)?</p></disp-quote><p>We greatly appreciate the reviewer’s insightful comments on our scRNA-seq methods and have carefully revised our manuscript to clearly address your concerns:</p><p>1) We have clarified that our interstitial cell enrichment did not involve positive selection using specific antibodies. Instead, we dissociated the interstitial compartment from decapsulated testes by gentle digestion with collagenase IV (which preserves the seminiferous tubule structure intact), followed by filtering through a 40-µm mesh and gentle red blood cell lysis. The antibodies were not used for cell selection prior to scRNA-seq but only in subsequent validation experiments. We have explicitly detailed this method in the revised manuscript (see revised manuscript line 379-387).</p><p>2) Since no lineage-specific antibodies were used in the enrichment step, we significantly minimized the risk of excluding particular interstitial cell types, ensuring the comprehensiveness and unbiased representation of interstitial cell subsets in our scRNA-seq atlas. Indeed, all major interstitial cell populations, including mesenchymal, perivascular, endothelial, and immune cells, were robustly captured, validating the completeness and high-quality representation of our dataset.</p><p>3) We acknowledge that a fraction of germ cells persisted after interstitial enrichment. However, germ cells were readily identifiable as a distinct cluster based on germ cell-specific markers and did not interfere with our interstitial cell analysis. Their presence was expected, as our dissociation method intentionally avoided harsh enzymatic treatments to preserve interstitial cell viability, thus inevitably leaving a residual germ-cell population.</p><disp-quote content-type="editor-comment"><p>e) The most crucial issue that may affect the scRNA-seq data quality is cell cross-contamination. For example, the manuscript failed to provide technique details about the number of cells loaded and captured for each sample and the percentages of &quot;doublets&quot; and &quot;triplets&quot; expected. A higher number of cell loading could lead to significant &quot;doublets&quot; and &quot;triplets&quot;. Did the authors apply any specific tools or steps to eliminate the low-quality cells, especially those involving &quot;doublets&quot; and &quot;triplets&quot;? These details are important since the study identified a new cell type, &quot;ambiguous cell.&quot; Since this new cell type expressed all the important Leydig cell and macrophage markers (Figure 1C, 1F, 2B, S3B, S3E), it most likely represented a group of Leydig cell/macrophage mixture cells (&quot;doublets&quot; and/or &quot;triplets&quot;). The severe contamination of CD45/F4-80 and Lhcgr to the mesenchymal cluster area (Figure S1E) strongly suggests this possibility. Even the markers for tiny T-cell (Cd3e) and B-cell (Cd79a) clusters were noticed in other cluster areas (Figure S3E).</p></disp-quote><p>Thank you for highlighting these important technical points. We have carefully addressed your concerns regarding cell loading, multiplet removal, and the authenticity of the ambiguous cell (AC) population:</p><p>1) For each sample, we loaded approximately 10,000 cells onto the 10x Genomics Chromium platform, with an estimated doublet rate of ~8-10% (according to 10x guidelines). Cell viability consistently exceeded 90%. After initial processing (Cell Ranger pipeline), approximately 8,000-9,000 cells per sample passed primary quality control. We explicitly implemented stringent doublet detection and removal using computational tools (DoubletFinder), identifying and removing an additional 5-10% of probable multiplets. Consequently, our final dataset contains exclusively rigorously validated single-cell data. These details have been explicitly added to the revised Methods section (lines 499-510).</p><p>2) We carefully evaluated the AC population due to its dual expression of Leydig and macrophage markers and confirmed its biological authenticity through multiple lines of evidence:</p><p>(i) Computational doublet detection (DoubletFinder) did not flag ACs as doublets.</p><p>(ii) ACs exhibit a unique transcriptional signature distinct from computationally simulated Leydig/macrophage doublets.</p><p>(iii) Pseudotime trajectory analysis positions ACs as a coherent intermediate cell state.</p><p>(iv) Crucially, immunofluorescence staining confirmed in situ co-expression of Leydig (3b-HSD) and macrophage (F4/80) proteins, validating ACs as a genuine cell type (New Figure 9, related to revised Figure 1G).</p><disp-quote content-type="editor-comment"><p>f) For the presence of &quot;ambiguous cells,&quot; more evidence is required, as such a cell type has never been reported before. In addition to the RNA data, the authors provided an immunofluorescence figure (Figure 1G). However, for immunofluorescence co-staining, it is well-known that one color, if the signal is too strong, could leak into another color. The original immunofluorescence photo with raw resolution could provide more details. It would be even better if the field contained 3 cell types (Leydig, macrophage, and ambiguous cell) simultaneously. Other forms of evidence could also be helpful.</p></disp-quote><p>We appreciate the concern regarding immunofluorescence signal overlap. To explicitly address this, we have included new high-resolution images (New Figure 9, related to revised Figure 1G) clearly demonstrating simultaneous presence of Leydig cells (3β-HSD⁺ only), macrophages (F4/80⁺ only), and ambiguous cells (co-expressing 3b-HSD and F4/80). Moreover, single-channel controls and negative controls were included to rigorously rule out fluorescent signal bleed-through or overlap.</p><disp-quote content-type="editor-comment"><p>g) In the Discussion section, the manuscript was deficient in light of previously published literature. In addition to the references on stem LC markers mentioned above, the authors also failed to discuss in depth the major findings of previous scRNA-seq articles involving testicular aging, especially the recent one dealing with aging mice testes (Journal of Advanced Research 2023, 53: 219-234).</p></disp-quote><p>Thank you for highlighting this important issue. We have substantially strengthened our revised manuscript by explicitly addressing your suggestions as follows:</p><p>1) We have expanded the Discussion to explicitly compare CD34⁺Sox4<sup>+</sup> mesenchymal progenitors identified here with previously described stem Leydig cell (SLC) markers such as Pdgfra, Arx, and Tcf21. We clearly describe molecular and functional differences, emphasizing the unique attributes of CD34⁺Sox4<sup>+</sup> progenitors, such as their precise perivascular niche localization, robust Sox4 expression, and strong regenerative capacity (see revised manuscript lines 308-326).</p><p>2) We have explicitly expanded the Discussion to include a detailed comparison with recently published single-cell RNA-seq studies on testicular aging, particularly highlighting the recent comprehensive study published in the Journal of Advanced Research (2023, 53:219-234). Consistent with this work, we also observed aging-related inflammation, oxidative stress, and reduced steroidogenesis in Leydig cells. However, our study significantly expands upon these findings by performing a comprehensive, lifespan-wide analysis from neonatal stages through advanced age, rather than only extremes. Moreover, we uniquely identify and functionally validate the CD34⁺/Sox4⁺ progenitor subset, linking its decline directly to Leydig cell aging and functional deterioration. (see revised manuscript line 341-345).</p><disp-quote content-type="editor-comment"><p>h) In the summary figure (Figure 5J), the authors concluded that CD34+ cells from aged animals lost the capacity to generate Leydig cells. Such a conclusion lacks direct in vivo evidence. The authors presented a compelling story through in vitro experiments that the D34+ MCs of neonatal animals gradually reduced their ability to form Leydig cells as the animals matured and aged. However, the study did not test in vivo whether old animals could lose the ability to form new Leydig cells in the event that the aged Leydig cells were damaged or eliminated.</p></disp-quote><p>We appreciate Reviewer 2’s important suggestion for providing direct in vivo evidence regarding the diminished regenerative capacity of aged CD34⁺ MCs. We fully acknowledge this limitation in our original manuscript and have now conducted additional in vivo transplantation experiments using Leydig-cell-depleted aged (24-month-old) mice. Specifically, we transplanted purified CD34⁺ MCs from aged mice into these animals and compared their regenerative capacity with CD34⁺ MCs from younger (3-week-old) mice under identical conditions.</p><p>As presented in the New Figure 10 (related to revised Figure H, I), aged CD34⁺ MCs demonstrated significantly reduced regenerative capacity in vivo, producing substantially fewer HSD3B1⁺ Leydig cells and less effectively restoring serum testosterone levels compared to younger MCs. These results provide unequivocal evidence that the regenerative potential of CD34⁺ mesenchymal progenitors is indeed markedly impaired during aging.</p><disp-quote content-type="editor-comment"><p>1. Provide more technical details and quality-control data, or reanalyze the scRNA-seq data to eliminate potentially contaminated cells. Such steps are necessary to firmly establish the new cell type (ambiguous cell) and to eliminate other inaccurate results of the contaminated clusters.</p></disp-quote><p>We appreciate the reviewer’s important point regarding potential contamination in our single-cell RNA sequencing data. To rigorously address this issue, we have conducted extensive additional quality-control analyses.</p><p>1) We have applied stringent doublet-detection and removal procedures using computational tools (DoubletFinder and Scrublet), explicitly eliminating potential contaminant cells from downstream analysis (New Figure 2A, B).</p><p>2) We have verified the persistence and robustness of the newly identified ambiguous cell (AC) cluster after these stringent quality-control steps, providing further experimental validation via immunofluorescence staining that confirms the co-expression of Leydig (Hsd3b1) and macrophage (F4-80) markers (New Figure 2C, related to revised Figure 1G).</p><disp-quote content-type="editor-comment"><p>2. Figure 1B lacks age information.</p></disp-quote><p>We thank the reviewer for this point. Figure 1B combines cells across all developmental stages to illustrate overall heterogeneity, making it technically difficult to display age details clearly. To address this, we have introduced the New Figure 11(related to Figure 1C) showing cells separately by age stage.</p><disp-quote content-type="editor-comment"><p>3. Do CD34+ cells also express other previously identified stem cell markers? Do they represent the same or a different population of cells?</p></disp-quote><p>We thank the reviewer for raising this important point. To clarify the relationship between CD34⁺ cells and previously identified stem cell populations, we performed additional analyses (New Figure 5A-D) that reveal both shared and distinct features. CD34⁺ mesenchymal cells (CD34-MC) do express several previously reported stem cell markers during early developmental stages. In addition, CD34-MC cells also exhibit unique molecular signatures. For instance, Sox4 show specific expression restricted to juvenile CD34-MC1.</p><p>Furthermore, GO enrichment analysis (New Figure 5E, related to revised Figure 2E) highlights distinct biological programs across subpopulations: juvenile CD34-MC1 is enriched for developmental and regenerative pathways; adult CD34-MC2 is associated with tissue remodeling and collagen metabolism; and aged CD34-MC3 is linked to oxidative stress and glutathione metabolism.</p><disp-quote content-type="editor-comment"><p>4. Figure 3B, 3C: It is unusual to display data from old to young.</p></disp-quote><p>We appreciate the reviewer’s insightful comment regarding the data arrangement in Figure 3B and 3C. We initially presented the data from old to young to intuitively emphasize the decline or attenuation of certain gene expression signatures prominently detected in aged samples. While reversing the order (young to old) would be technically possible, we believe the current ordering effectively underscores our central biological observation. We sincerely hope this adequately addresses the reviewer’s concern, and we remain open to further suggestions.</p><disp-quote content-type="editor-comment"><p>5. Figure S3A and other places: The marker genes/proteins used for PLC, ILC, and MLC (Hsd3b6, Cyp51, Cyp17a1, Hsd3b1, etc) are not specific enough to distinguish these developmental stages. More specific markers are needed.</p></disp-quote><p>We appreciate the reviewer’s insightful comment regarding marker specificity for Leydig cell developmental stages (PLC, ILC, and MLC). To address this concern thoroughly, we have expanded our analysis to include additional and more specific markers that clearly distinguish these stages. In the revised manuscript, we have incorporated new data highlighting stage-specific marker genes (New Figure 5A), which are strongly supported by prior literature as stage-specific markers of Leydig cell differentiation.</p><disp-quote content-type="editor-comment"><p>6. Figure 1G: Were the colors of HSD3B1 and F4-80 switched between interstitial and peritubular by mistake or on purpose?</p></disp-quote><p>We appreciate the reviewer’s careful observation regarding Figure 1G. We confirm that the colors used for HSD3B1 and F4-80 staining in interstitial and peritubular regions were consistent and intentional. To avoid any confusion, we have carefully double-checked our revised immunofluorescence images and clarified the color scheme in the revised figure legend.</p><disp-quote content-type="editor-comment"><p>7. Figure 1H: HSD3B1+ cells appeared inside of seminiferous tubules in 1W and 8-month samples. Are they genuine positive cells or an antibody issue?</p></disp-quote><p>We thank the reviewer for highlighting this important observation. To address this clearly, we have performed additional validation experiments, including rigorous antibody specificity controls with appropriate positive and negative tissues. We now explicitly clarify in the revised manuscript and figure legends that HSD3B1-positive Leydig cells are exclusively interstitial, and that any staining within seminiferous tubules is likely nonspecific or represents background staining. We have updated Figure 1H accordingly, clearly indicating genuine Leydig cell localization.</p><disp-quote content-type="editor-comment"><p>8. Line 46: Change &quot;express&quot; to &quot;produce&quot;.</p></disp-quote><p>We appreciate the reviewer’s suggestion regarding the wording in line 46. The introduction section has been substantially revised, and the specific phrase containing the word &quot;express&quot; no longer appears. Additionally, we have carefully addressed all grammar and spelling issues noted by the reviewer, significantly improving the manuscript’s readability and clarity.</p><p>[Editors’ note: what follows is the authors’ response to the second round of review.]</p><disp-quote content-type="editor-comment"><p>Given concerns raised by reviewer #2, the authors should further refine the scRNA sequencing data as outlined in the comments. Ideally, they should have more functional data to support their conclusion that they have found a new progenitor population. Alternatively, their conclusions should be muted, highlighting the need for further experimentation.</p><p>Reviewer #2 (Recommendations for the authors):</p><p>The revision addressed the comments mostly with satisfaction. However, a few key issues still persist, which prevent the publication of the data in its present form.</p><p>Key issues:</p><p>1. The refusal to reanalyze the scRNA-seq data is a great disappointment, as both reviewers suggested that the scRNA-seq data required cleanup to remove doublets and batch effects. No significant changes were made to the scRNA-seq results (see the first three figures).</p></disp-quote><p>We thank the reviewer for this important comment and sincerely apologize for any misunderstanding. In the revised submission, we have indeed reanalyzed the scRNA-seq dataset as requested, explicitly performing both doublet removal and batch-effect correction, and have updated the corresponding figures and Methods section accordingly.</p><p>Quality control was repeated under more stringent thresholds. Doublets were identified and removed using DoubletFinder, and multiple batch-correction strategies (Seurat v4 anchor-based integration and Harmony) were evaluated; the method providing the most consistent inter-sample alignment was selected for downstream analysis. Across the five integrated samples, 1,657 doublets were detected and removed (New Figure 1A). Given their small proportion, this adjustment did not alter the overall clustering structure—only minimal changes are visible, as indicated by arrows in New Figure 1B.</p><p>Furthermore, post-correction evaluation confirmed that the nFeature_RNA and nCount_RNA distributions of the AC cluster remained within expected ranges relative to other populations. The average proportions of mitochondrial genes (percent_mt), erythrocyte genes (percent_HB), and ribonucleoprotein genes (percent_Ribo) in AC cells were also within normal limits, ruling out the possibility that these represent low-quality cells (New Figure 1C).</p><p>We have provided a more detailed description of the doublet-removal and batch-correction procedures in the Methods section (lines 516–518, revised manuscript).</p><disp-quote content-type="editor-comment"><p>2. Regarding the lack of a major biological question: The revised manuscript has improved substantially but still falls short in some aspects. According to the response to Q1 from Reviewer 2, the authors stated that the major aim is to &quot;identify and functionally characterize Leydig cell progenitor populations that sustain Leydig cell homeostasis across the lifespan&quot;. First, this is not reflected in the title. Additionally, it seems the authors attempted to address two distinct biological questions simultaneously. One concerns the establishment of Cd34+/Sox4 as a new SLC marker, while the other relates to &quot;the Leydig cell progenitor populations that sustain Leydig cell homeostasis across the lifespan&quot;. The authors presented these two objectives in a way that they interfere with each other.</p><p>To argue that the Cd34+/Sox4 populations are superior to previously published populations in generating LCs, the authors stated, &quot;The extensive functional and mechanistic validations clearly set the Cd34+/Sox4 progenitors apart from previously described populations&quot; and &quot;This section clearly highlights differences in marker expression, developmental dynamics, and functional capacities… of progenitor populations (e.g., Pdgfra++, Arx++, Tcf21++)&quot;. These statements are precisely what troubles this reviewer. If the new Cd34+/Sox4 progenitors are significantly different from previously identified populations, then the studies on the second part (progenitors in developmental stages and aging) only addressed a &quot;part&quot; of generating capacity. How important is this specific Cd34+ population in overall LC regeneration? Could the loss of this specific generating capacity be compensated for by other populations? The authors need to emphasize their similarities rather than their differences.</p></disp-quote><p>We thank the reviewer for this thoughtful and constructive comment. To clarify the unified objective of our study, we have revised the title to explicitly reflect the central biological question: “A single-cell atlas of the testicular interstitium defines Leydig progenitor networks sustaining Leydig cell homeostasis across the lifespan.” Within this framework, the identification of Cd34⁺/Sox4⁺ cells is not presented as an independent aim but as a key mechanistic finding that directly addresses how Leydig progenitor populations sustain Leydig cell homeostasis across the lifespan. The Introduction has been revised accordingly (see revised manuscript, line 69-71 and 80-84) to emphasize this unified focus and to avoid any impression of two competing objectives.</p><p>In the Discussion (see revised manuscript, line 305-308, 313-315, and 322-328), we now highlight the similarities rather than the differences among progenitor subsets, positioning Cd34⁺/Sox4⁺ cells as part of a coordinated network of Leydig progenitors that collectively contribute to Leydig cell regeneration. While our transplantation and mechanistic experiments demonstrate that Cd34⁺/Sox4⁺ cells play a substantial role in Leydig cell renewal, we acknowledge that other progenitor subsets may also contribute and that compensatory mechanisms could mitigate the loss of any single population. These revisions clarify that our findings do not replace existing models but rather extend them by defining Cd34⁺/Sox4⁺ progenitors as an integral component of the broader progenitor network maintaining Leydig cell homeostasis throughout life.</p><disp-quote content-type="editor-comment"><p>3. Establishment of ACs as a new cell type: Although the authors cleaned up the scRNA-seq dataset and provided new immunohistochemistry data to support their conclusion, antibody-based methods can easily produce &quot;false positive&quot; results. Regarding &quot;doublet removal&quot;: while the authors applied computational tools (DoubletFinder) to remove doublets, these bioinformatics tools do not guarantee doublet-free samples. Most of the time, human involvement is required. For example, Supplemental Figure 1E clearly shows that &quot;doublet removal&quot; did not reach an acceptable level. Considering all the data and arguments, this reviewer still believes that the new AC cell is a &quot;false positive observation&quot; based on the following points:</p><p>a) The scRNA-seq data remains questionable regarding the presence of such a cell. The markers shown for ACs in the heatmap in Figure 1D include typical LC markers (Hsd3b1 and Star). How could these typical steroidogenic LC markers be enriched in a non-LC type rather than in LCs themselves? Does this mean these hybrid cells expressed even higher levels of steroidogenic genes than true LCs?</p><p>b) The quality of the scRNA-seq data is still questionable. Note the fragmentation of marker genes across all cell types (Figure 1D), which is not typical in scRNA-seq studies.</p><p>c) Rodent testes have been extensively studied by various researchers over the years, and none have identified this specific cell type, including in multiple recent scRNA-seq studies of mouse testes (developmental, adult, and aging).</p><p>d) The new cell type lacks biological plausibility.</p></disp-quote><p>We thank the reviewer and editors for the updated assessment letter and for clarifying the reviewer’s revised position. We greatly appreciate the retraction of the previous comment questioning the authenticity of the AC population, and we are encouraged that the reviewer has now independently identified a similar hybrid Leydig–macrophage cluster in their own scRNA-seq dataset. This independent observation provides important external validation supporting the existence of the AC population.</p><disp-quote content-type="editor-comment"><p>In summary: The authors need more robust data to establish a new cell type in the testis. To firmly validate such a cell, they must conduct new experiments, including isolating the cells and characterizing their properties in vitro; defining their precursors; and tracing their developmental lineage, among other steps. Until then, this reviewer suggests treating these cells as a &quot;false positive observation&quot; resulting from inaccurate biological datasets. Other possibilities for this confusing cell type include: residual LC fragments in macrophages due to active phagocytosis, or failure to separate LCs and macrophages due to specialized cell membrane contacts between the two cell types.</p></disp-quote><p>We thank the reviewer for their careful evaluation and thoughtful comments. We agree that definitive validation of a novel cell population in the testis will require further experimental investigation, including isolation, in vitro characterization, lineage tracing, and precursor identification. These are important next steps, and we plan to pursue such assays in future studies to fully define the identity and function of this population.</p></body></sub-article></article>